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DNA damage is a common hazard that all cells have to combat. Saccharomyces 
cerevisiae HMO2 is a high mobility group protein (HMGB) that is a component of the chromatin 
remodeling complex INO80, which is involved in double strand break repair. I show here using 
DNA end-joining and exonuclease protection assays that HMO2 binds preferentially to DNA 
ends. While HMO2 binds DNA with both blunt and cohesive ends, the sequence of a single 
stranded overhang significantly affects binding, supporting the conclusion that HMO2 
recognizes features at DNA ends. Analysis of the effect of duplex length on the ability of HMO2 
to protect DNA from exonucleolytic cleavage suggests that more than one HMO2 must assemble 
at each DNA end. HMO2 binds supercoiled DNA with higher affinity than linear DNA and has a 
preference for DNA with lesions such as pairs of tandem mismatches; however, comparison of 
DNA constructs of increasing length suggests that HMO2 may not bind stably as a monomer to 
distorted DNA. The remarkable ability of HMO2 to protect DNA from exonucleolytic cleavage, 
combined with reports that HMO2 arrives early at DNA double strand breaks, suggests that 
HMO2 may play a role in double strand break repair beyond INO80 recruitment. I also found 
that HMO2 has the ability to mediate both 3′ and 5′ DNA strand invasion, which is an essential 
step in homologous recombination. Also hmo2∆ and hmo2∆rad52∆ have slower growth 
phenotype in presence of hydroxyurea thus indicating that HMO2 might play important role in 






To orchestrate the processes of DNA replication, transcription, recombination and repair 
involves maneuvering the structure of the DNA.  Architectural proteins play a significant role in 
interacting with the DNA and execute the cellular processes. Amongst several architectural 
proteins known, high mobility group proteins (HMG) have been shown to extensively interact 
with the DNA and introduce distortions to the existing DNA structure.  HMG proteins have been 
shown to have preference for altered DNA conformations such as four-way junctions, DNA with 
nicks, loops, gaps and overhangs. HMG proteins also have the ability to promote DNA end 
joining and DNA bending. Here I characterize one of the ten HMG box proteins (HMGB) in 
Saccharomyces cerevisiae, HMO2 also known as non-histone protein 10 (NHP10). Although 
HMO2 exhibits properties like other HMG proteins, its uniqueness is its remarkable property to 
bind DNA ends and protect it from exonuclease III digestion and to mediate 5′ and 3′ DNA 
strand invasion. 
High Mobility Group Proteins (HMG) 
 High Mobility Group Proteins are non-histone chromosomal proteins found ubiquitously 
in eukaryotes. Depending on the DNA binding characteristic, HMG proteins are classified into 
three divisions, HMGA, HMGB and HMGN (1, 2). HMGA proteins are characterized by an AT 
hook motif, which is positively charged and containing an invariant tripeptide 
glycine/arginine/proline, flanked by arginine residues (3). The AT hook binds DNA through the 
minor groove with the sequence AA(T/A)T (3, 4). HMGN proteins consist of nucleosomal 
binding domains that recognize the nucleosomes (3, 5). HMGB proteins comprise one or more 
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HMG boxes. Each HMG box is ~80 amino acids (1, 2) and are further classified into two 
categories depending on sequence specificity. The sequence specific family includes for example 
lymphoid enhancer factor (LEF) and sex determining factor (SRY), while the non-sequence 
specific family comprises of HMGB1, HMGB2 (1-3, 6-8). 
Structure of HMGB Proteins 
The HMG box is composed of three α-helices, which adopt an „L‟ shaped fold (2, 6-8). 
DNA binding occurs through the minor groove by partial intercalation of hydrophobic amino 
acid residues, which results in bending the DNA (9, 10). Many structures of HMG boxes, 
including members of both sequence-specific and non-sequence specific family have been 
determined in the presence or absence of DNA. The HMGB proteins contain tandem DNA 
binding HMG box domains A and B, linked by a linker region (9) followed by an acidic C-
terminal tail rich in aspartates and glutamates, with exception of yeast HMO1 which has a lysine-
rich tail (11). The structure of sequence-specific HMGB protein is determined with or without its 
cognate DNA.  The 3 helix fold structure of HMG protein is indicated in Fig.1.1(12). 
Structures of SRY and LEF-1 have been determined using the cognate DNA (Fig.1.2), (8, 
9, 13). Using NMR-spectroscopy, solution structures of HMGB box A and box B have been 
determined. Also the structure of yeast NHP6 has been reported (9, 14, 15). The HMG box is a 
global fold „L‟ shaped motif comprising of three α-helices (16, 17). The helices I and II have 
short arms whereas helices III comprises of a long arm. Until recently, there was no structure of 
non-sequence-specific HMGB protein bound with DNA. Recently, HMG box di domain bound 






Fig.1.1 HMG box structure indicating the L-shaped fold of the HMG domain. (Generated using 










The two classes of HMGB proteins vary in their interaction with DNA. The first class 
comprising of HMG proteins that typically have a single HMG domain, are transcription factors 
that binds to DNA with sequence specificity. The second class comprises of HMG proteins that 
comprises of two tandem HMG domains, and binds to DNA with little or no sequence specificity 
(18). Both the classes of HMGB of proteins display affinity for distorted DNA and also induce 
bends in the DNA. The structures of sequence dependent proteins SRY and LEF have been 
reported (8, 19). The second class of HMGB proteins typically has two tandem HMG boxes 
namely Box A and Box B. The Box A has preference for four-way junctions and cis-platin 
modified DNA (12, 20), whereas Box B has preference for distorted DNA, indicating that Box B 
has preference for static DNA distortions (17). Recently the structure of tandem HMG boxes has 
been reported. It comprises of the Box B and the Box A has been replaced by SRY. The SRY 
region hydrophobic wedge in helix I comprises of methionine9, phenylalanine12 and 
isoleucine13(9). Box B features two intercalating sites phenylalanine97 in helix I and isoleucine 
116 in helix II as indicated in Fig.1.2 (9).  
DNA Binding Targets of HMGB Proteins  
The HMGB proteins bind DNA through the minor groove. DNA binding occurs with 
hydrophobic amino acid residues, which protrude from the concave surface of the protein and 
then interact with the DNA bases by partial intercalation (Fig 1.3) (3, 10). HMGB proteins 
preferentially bind to distorted DNA and DNA binding by these architectural proteins induces 
bending in the DNA (21). SRY binds to the minor groove of the DNA and bends the helix ~80° 
towards the major groove, whereas LEF-1 bends DNA by 107°(21). HMGB proteins also have 
preference altered DNA structures like four-way junctions, stem and loops or kinked DNA (3, 





Fig.1.2 The structure of SRY (in green) and Box B (in orange) didomain with DNA (in blue). 
The hydrophobic residues are indicated in red. (Structure generated using pdb accession id 2gzk 











Fig.1.3 Interaction of HMGB1 Box A domain (light green) with DNA (light orange). The 
interaction is by partial intercalation of the hydrophobic amino acid residue phenylalanine (in 
red) in helix II as indicated by the arrow (12). The figure is generated using the pdb accession id 








The Box A domain of HMGB proteins also bind to cis-platin modified DNA (12, 23), by 
intercalation of a phenylalanine present at helix II, indicated in fig.1.3. HMGB proteins 
participate in various DNA dependent processes such as transcription, recombination and 
stabilizing the chromatin structure. 
Saccharomyces cerevisiae HMGB Proteins 
Saccharomyces cerevisiae contains ten HMGB proteins. NHP6A/B are single HMG box 
proteins of ~10 kDa, and they participate in transcription by RNA polymerases II and III (24-27). 
HMO1 and HMO2 are ~25 kDa proteins which are similar to mammalian HMGB proteins and 
have two HMG like domains. HMO1 plays important roles in plasmid maintenance and normal 
growth of the cell. HMO1 has been shown to participate in ribosomal RNA transcription and to 
regulate ribosomal protein expression (in response to TOR signaling, not otherwise) (28-33). 
Both HMO1 and HMO2 comprise of Box A and Box B domains. The Box B domain 
corresponds to mammalian HMG domain whereas Box A bears little resemblance to mammalian 
Box A (11, 34). HMO1 Box A domain participates in DNA binding and DNA bending (11, 35). 
It has also been reported that HMO1 helps in maintenance of the chromatin structure (11). The 
other HMG domain containing protein reported in yeast is Ixr1which has been shown to bind to 
cis-platin DNA adducts (36). 
 Recently HMO2 has been reported to be a subunit of the ATP-dependent chromatin 
remodeling complex INO80. The INO80 complex has been shown to participate in double strand 
break (DSB) repair in yeast (37-41). The INO80 complex is recruited to the DSB by the damage-
induced phosphorylated histone H2A (γ-H2AX) and this phenomenon requires HMO2 (37).  
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 Here I show that HMO2 like other HMGB proteins has preference for DNA with lesions 
but has modest preference for four-way junctions.  But unlike other HMGB proteins HMO2 
binds to DNA ends, both cohesive and blunt, and protects the DNA from exonuclease III 
cleavage. Thus it could be speculated that HMO2 may play a role beyond just recruiting INO80 
to DSB (34). 
Chromatin Remodeling Complex INO80 and Double Strand Break Repair 
Chromatin Remodeling Complex INO80 
 Chromatin remodeling is a very important function for the DNA dependent processes like 
transcription, recombination and repair. HMGB proteins have been shown to bind to various 
types of distorted DNA and aid in damaged DNA recognition and help in DNA repair. (42). 
Eukaryotes have two ways to deal with the barrier to the chromatin structure; firstly by covalent 
modification of the histone tails such as phosphorylation or acetylation, secondly by the ATP-
dependent chromatin remodelers (40). 
 Yeast INO80 complex is an ATP dependent chromatin remodeling complex comprising 
of 12 subunits, where Ino80 is the ATPase. The other subunits include actin related protein 
(Arp), Arp4, Arp5 and Arp8, which help in histone binding (40). It also consists of Rvb1 and 
Rvb2, which has 3′-5′ helicase activity. It has been demonstrated that mutants of ino80 are 
hypersensitive to DNA damaging agents (43). One of the major types of damage caused to the 
DNA is the double strand break which occurs, for example, due to the ionization radiation. The 
early response to this DNA damage event is phosphorylation of the histone H2A by the 
ATM/ATR kinases (40). It has been recently reported that in absence of INO80, H2AZ 
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nucleosomes are not well localized, suggesting that INO80 plays an important role for H2AZ 
responsiveness (44, 45). 
Recruitment of the INO80 Complex to the Region of Double Strand 
Break 
 
The cell cycle checkpoint kinases in yeast ATM/ATR Tel1 in association with 
Mre11/Rad50/Xrs2 (MRX) complex and Mec1 with Dcd2 phosphorylates the H2A at serine 129 
(Fig.1.4) (40, 46-48). INO80 binds to phosphorylated H2A (γ-H2AX) and this requires HMO2 
(43). The INO80 complex might then slide along the phosphorylated H2A or remain localized at 
the region of double strand break, the functionality is still unknown (40). 
Other Functions of INO80 Complex 
INO80 complex has been shown to participate in double strand break (DSB) repair, and 
recently shown to have other functions. INO80 has been shown to interact with the early 
nucleotide excision repair (NER) damage recognition complex Rad4-Rad23 in UV dependent 
manner and to help in removal of UV photo product (49, 50). INO80 complex has also been 
reported to help repair and release stalled replication forks (51, 52). 
Double Strand Break Repair 
 Double strand breaks are initiated by ionization radiation and can be extremely hazardous 
for the cells. The repair of the DSBs is thus pivotal for maintaining the genome stability. 
Eukaryotes repair the DSBs via non-homologous end-joining (NHEJ) and homologous 
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cycle; the ends are resected leading to a 3′ single stranded end, which would invade the 
homologous strand forming a D-loop intermediate, followed by formation of Holliday junction, 
branch migration and resolving the DNA (54). NHEJ in yeast is mediated by Ku and 
Mre11/Rad50/Xrs2 complex (55). 
Mechanism of Double Strand Break DNA Repair 
 DNA double strand breaks (DSB) are induced as a consequence of ionization radiation 
and repair of DSB is essential for maintaining genomic stability (55, 56). Double strand break 
repair occurs mainly via two pathways, i) Homologous recombination (HR) and ii) non-
homologous end joining (NHEJ). 
Homologous Recombination (HR) 
 Once a DSB is detected, the end of the DNA is resected by Mre11 and exonuclease 1 
(exo 1). The ssDNA overhang is then coated by replication protein A (RPA) which is further 
replaced by Rad51. Further with help of Rad52, Rad55 and Rad57 initiates strand invasion event 
using the homologous DNA counterpart forming a D-loop, following Holliday junctions 
intermediate following branch migration. Final step involves resolving the double Holliday 
junction (54). The events of HR are indicated in Fig.1.5. 
Non-Homologous End-joining (NHEJ) 
 The NHEJ is illegitimate or error-prone DSB repair. On induction of DSB, the DNA ends 
are bound by Ku proteins. This event leads to binding of the MRX complex to the DNA end 




















DNA polymerase Pol4 and then the DNA ends are ligated. The events of NHEJ are indicated in 
Fig.1.6 (55) 
Here I elucidate functions of HMO2, a yeast HMGB protein, which is a component of the 
ATP-dependent INO80 chromatin remodeling complex. INO80 has been shown to help in DSB 
repair in yeast. I have shown that HMO2 binds to DNA ends and protects it from exonuclease III 
digestion. HMO2 comprises of two HMG domains, which like other HMG domains have 
preference for distorted DNA. I also show that HMO2 can promote DNA strand invasion. 
Interestingly hmo2∆ shows sensitivity to hydroxyurea which stalls DNA replication fork. These 
observations  indicate that HMO2 might aid INO80 in DNA repair in yeast. 
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THE YEAST HIGH MOBILITY GROUP PROTEIN HMO2, A SUBUNIT 
OF THE CHROMATIN-REMODELING COMPLEX INO80, BINDS DNA 
ENDS* 
Introduction 
All organisms depend on efficient repair of DNA double strand breaks (DSBs) to 
maintain genomic stability (1, 2). The most accurate repair pathway is homologous 
recombination (HR), which is mainly active during S and G2 as it depends on the presence of 
sister chromatids, while the more error prone non-homologous end-joining (NHEJ) is active 
throughout the cell cycle (2). Both repair pathways must negotiate DNA that is packaged into 
chromatin, and chromatin remodeling is therefore critical to DNA repair (3-7).
 
The ATP-dependent chromatin remodeling complex INO80 has been recently shown to 
participate in DSB repair in yeast (3, 8-11). The INO80 complex is recruited to the DSB by 
interaction with the damage-induced phosphorylated histone H2A (γ-H2AX), a phenomenon that 
requires the high mobility group protein HMO2 (also known as NHP10). HMO2 has been 
reported to be responsible for interaction with γ-H2AX and its inactivation results in reduced 
INO80 recruitment to the DSB, but not to impaired chromatin remodeling activity (3). Since 
H2A phosphorylation is thought to be an early response to DSB formation, INO80 – and hence 
HMO2 – may contribute to DSB repair by both pathways. 
 
 





High mobility group (HMG) proteins are non-histone chromosomal proteins that are  
classified into three groups, HMGA, HMGB and HMGN depending on their DNA binding 
characteristics (12,13). HMGB proteins contain one or more HMG boxes, an ~80 amino acid 
sequence (13,14), and are further classified into two groups depending on sequence specificity; 
the sequence-specific family consists of transcription factors such as lymphoid enhancer factor 
(LEF) and sex-determining factor (SRY), while the non-sequence specific family includes 
HMGB1, HMGB2 and yeast homologs NHP6A and NHP6B (12,14-19). The HMG box is 
composed of three α-helices which adopt an 'L' shaped fold (14-17, 19-21). Binding to the DNA 
occurs through the minor groove by partial intercalation of hydrophobic amino acids, resulting in 
DNA bending (12,18,21), and HMGB proteins preferentially bind to distorted DNA such as cis-
platin-modified DNA (22,23). HMGB proteins participate in stabilizing chromatin structure and 
play a role in DNA-dependent processes such as recombination and transcription by facilitating 
nucleoprotein complex assembly. HMGB proteins have also been suggested to contribute to 
DNA repair, as evidenced for example by DNA end-joining in vitro in the presence of DNA 
ligase (24-27).
 
Saccharomyces cerevisiae contains 10 HMGB proteins. The single HMG box proteins 
NHP6A/B participate in transcription by RNA polymerases II and III (18,28-30). HMO1 and 
HMO2 are more similar to mammalian HMGB proteins by having two HMG-like domains, Box 
A and Box B. HMO1 has been shown to play a role in plasmid maintenance and normal growth 
and it also functions in the ribosomal RNA transcription system as well as in regulating 
ribosomal protein expression (31-36). In the approximately 25 kDa HMO2, the two domains Box 
A and Box B are followed by an acidic C-terminal tail in contrast to HMO1, which has a lysine-
rich tail. For both HMO1 and HMO2, Box B corresponds to the mammalian Box B while the N-
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terminal Box A bears little resemblance to mammalian Box A. The HMO1 Box A domain has 
been shown to contribute to DNA binding and bending (37,38).
 
We show here that HMO2 binds to DNA ends, both blunt ends and overhangs, and that it 
protects DNA from exonuclease digestion. Since protection of DNA ends from exonucleolytic 
cleavage is essential to minimize loss of genetic information before repair can be initiated, and 
since HMO2 is thought to arrive early at DSBs in its complex with INO80 components, our data 
suggests that HMO2 may play a role in DSB repair beyond INO80 recruitment. 
Materials and Methods 
Cloning, Overexpression and Purification of Protein 
The gene encoding HMO2 was amplified from yeast genomic DNA using primers 
NHP10F 5'-CACATAAGCATATGTCAGTTGAA-3' and NHP10R 
5'-CGTCTTACCATATGTTCAAAGAA-3' (NdeI sites underlined) and cloned into the NdeI site 
of pET14b, resulting in expression of HMO2 with an N-terminal His6-tag. pET14b-HMO2 was 
transformed into E. coli Rosetta Blue and expression of HMO2 was induced by addition of 1 
mM isopropyl--D-thiogalactopyranoside (IPTG) at A600 of 0.2 and induction was carried out for 
4 hours. Cells were pelleted and then resuspended in lysis buffer pH 7.5 (50 mM NaxHyPO4, 300 
mM NaCl, 10 mM imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM 
phenylmethylsulfonyl fluoride (PMSF). Cells were disrupted by sonication. The nucleic acids 
were digested by adding 2 μl of 2000 U/ml of DNaseI (New England Biolabs) and incubated on 
ice for one hour. To the lysate, 0.01% of Triton X-100 was added and the solution was incubated 
on ice for 1 hour and then centrifuged at 6000xg for 20 min. The lysate was incubated with Ni-
NTA agarose beads for 1 hour on ice. The nickel beads were equilibrated using lysis buffer prior 
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to use. The beads were washed using wash buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 20 
mM imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM PMSF). Proteins were eluted 
by gravity flow using elution buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 250 mM 
imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM PMSF). Pure HMO2 was 
quantitated using Coomassie blue stained SDS-PAGE gels using bovine serum albumin as 
standard as well as by Micro BCA Protein Assay Kit (Pierce). At least three independent 
preparations of HMO2 were used, indicating reproducibility of the preparations. HMO1 was 
obtained as described previously (37).
 
Agarose Gel Retardation 
One hundred ng of supercoiled or linear pGEM5 was incubated at 4°C with different 
concentrations of HMO2 in 10 μl reaction buffer (20 mM Tris pH 8.0, 0.1 M EDTA, 15 mM 
NaCl, 0.1 mM DTT and 0.01% BRIJ 58). Complexes were resolved using 1% TBE agarose gels 
using 0.5X TBE buffer (50 mM Tris borate, 1 mM EDTA) and visualized by ethidium bromide 
staining. 
DNA Supercoiling 
Supercoiled pUC18 was nicked using Nt.BstNBI (New England Biolabs). One hundred 
ng of nicked DNA was incubated with varying concentration of HMO2, at room temperature for 
1 hour. Reactions were initiated using 1 μl of 80 U/μl of T4 DNA ligase (New England Biolabs) 
in presence of ligase buffer and incubated at room temperature for 1 hour. Reactions were 
terminated using 1 μl stop buffer (5 mM EDTA, 1.1% glycerol and 0.2 mg/ml proteinase K final 
concentration) and incubated at 37°C for 1 hour. Samples were loaded on 1% TBE agarose gels 
and electrophoresed for 14 hours followed by staining with ethidium bromide. For determination 
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of the direction of DNA supercoils produced by HMO2, electrophoresis was performed in the 
presence of 0.3 µg/ml chloroquine, using Bacillus subtilis HU as a control. 
Electrophoretic Mobility Shift Assay 
All oligonucleotides used for preparation of DNA constructs were purchased and purified 
by denaturing gel electrophoresis. Sequences are available in Supplementary Table 1. EMSAs 
were performed using DNA duplex and DNA with loops, nicks, gaps and overhangs. A common 
37 nt oligonucleotide was used to generate the different constructs. The top strand was 5' end 
labeled using T4 polynucleotide kinase (New England Biolabs) and [γ
32
P] ATP. The sequences 
of duplex as well as DNA with nick, gap, loops and overhangs were as described in (39) or 
presented in Table 2.1. Top and bottom strands were annealed by heating at 90°C and slowly 
cooling to room temperature. Similarly, a 50 bp DNA duplex and duplex with either a single or 
tandem loops was generated by extending the 37 bp construct at both ends. Reactions contained 
5 fmoles of DNA substrate and varying concentration of HMO2 in 10 μl reaction buffer (20 mM 
Tris pH 8.0, 0.1 mM EDTA, 5 mM NaCl, 0.1 mM DTT, 0.01% BRIJ 58 and 0.1% Triton X-100) 
and incubated at room temperature for one hour. Experiments designed to compare different 
DNA constructs were performed side-by-side with the same protein preparation. Samples were 
loaded on a prerun 8% polyacrylamide gel (39:1 acrylamide:bisacrylamide) and electrophoresed 
using 0.5X TBE at 175 volts for 2 hours. Complexes were visualized using Amersham 
Biosciences Storm Phosphorimager. Reactions were performed at least in duplicate. 
EMSA with Four Way Junctions (4WJ) 
The sequence of the four-way junction was described in (39) and shown in Table 2.1. 
Four-way junctions were obtained by 5'-end labeling one strand and annealing the other three 
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strands, followed by purification using native polyacrylamide gels. Complete annealing of all 
strands was determined by comparing the electrophoretic mobility to that of annealed constructs 
lacking one of the unlabeled strands. EMSA was performed as described above using 5 fmoles of 
DNA and varying concentration of HMO2 in reaction buffer. Final volume of the reaction was 
10 μl. 
          Competition Assay  
Five fmoles 50 bp duplex DNA with loops and 4 μM of HMO2 was incubated at room 
temperature for 1 hour in reaction buffer. Supercoiled or linear pGEM5 (0.5-50 fmoles) was 
added and incubated at room temperature for 1 hour; pGEM5 was linearized with NdeI or AatII. 
Samples were electrophoresed on prerun 8% polyacrylamide gels. Complexes were viewed using 
Storm Phosphorimager. 
End-joining Assay 
Supercoiled pGEM5 was digested with NdeI or NaeI to obtain DNA with a 2-nt 5' 
overhang or blunt ends, respectively. One hundred ng of linearized pGEM5 was incubated with 
varying concentrations of HMO2 or HMO1 at room temperature for 1 hour. To this reaction, 1 μl 
of 400 U/μl of T4 DNA ligase was added and incubated at room temperature for 1 hour. Samples 
were treated with exonuclease III (100U/μl) at room temperature for 1 hour. Reactions were 
terminated by adding 2 μl stop buffer (5 mM EDTA, 1.1% glycerol and 0.2 mg/ml proteinase K). 
Alternatively, supercoiled pET5a was digested with BspHI, which creates a 4-nt 5' overhang. 
One hundred ng of the linearized pET5a was incubated with 2 µM HMO2. To this reaction 1 µl 
of 400 U/µl of T4 DNA ligase was added and incubated at room temperature for 1 hour. 
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Reactions were terminated by adding 2 µl of stop buffer. Samples were electrophoresed on 1% 
TBE agarose gels and visualized by ethidium bromide staining.  
Using forward primer 5'-TGGGGTGCGAATTCTAATGAGT-3' and reverse primer 5'-
GGCTTTACACTTTATGCTTCCG-3', an extra EcoRI site was introduced into plasmid pUC18 
by PCR amplification. The pUC18 variant was then digested with EcoRI to obtain 105 bp DNA 
duplex with 5'-AATT extensions. The 105 bp DNA was 5'-end labeled using T4 polynucleotide 
kinase (New England Biolabs). One hundred femtomoles of 105 bp DNA was incubated with 
varying concentrations of HMO2 or 100 nM Bacillus subtilis HU at room temperature for one 
hour. To this reaction, 1 µl of 8 U/µl T4 DNA ligase was added and incubated at room 
temperature for one hour. Samples were treated with exonuclease III (100 U/µl) at room 
temperature for 1 hour. Reactions were terminated by adding 2 µl stop buffer and 1 µl of 10% 
SDS and then phenol chloroform extracted and ethanol precipitated.  Samples were loaded on a 
prerun 5% polyacrylamide gel (39:1 acrylamide:bisacrylamide) and electrophoresed using 0.5X 
TBE at 175 volts for 2 hours. Complexes were visualized using Amersham Biosciences Storm 
Phosphorimager. 
Exonuclease III Protection Assay 
Supercoiled pGEM5 was linearized with NdeI or NaeI to yield DNA with 2-nt 5' overhangs or 
blunt ends, respectively. pET5a was digested with BspHI to produce 4-nt 5' overhang, pUC18 
was digested with EcoRI, which also produces a 4-nt 5' overhang, and a pcDNA3-derivative was 
digested with ApoI, which likewise creates a 4-nt 5' overhang. pET5a was digested with ScaI and 
then PvuI (which cuts supercoiled DNA only poorly), to yield a blunt end and 2-nt 3' overhang, 
respectively. pRAD1 was digested with DraI to produce blunt ends. Fifty to one hundred ng of 
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linearized pGEM5, pET5a, pUC18, pcDNA3-derivative and pRAD1 was incubated at room 
temperature for one hour with 2 μM HMO2 or HMO1 previously dialyzed using dialysis buffer 
(50 mM Tris pH 8.0, 50 mM NaCl and 20% glycerol). To each reaction, 1 μl of 100 U/μl 
exonuclease III was added and incubated at room temperature for 1 hour. Reactions were 
terminated by addition of 2 μl 10% SDS or by phenol-extraction and ethanol precipitation (the 
latter in cases where shorter DNA fragments are produced that may co-migrate with SDS on the 
gels). Samples were electrophoresed on 1% TBE agarose gels. Gels were stained with ethidium 
bromide. All reactions were performed at least in duplicate, and pGEM5 digested with NdeI to 
produce 5'-TA overhangs was included for comparison to other DNA constructs. 
DNase I Protection Assay 
One hundred ng of supercoiled or linearized pGEM5 with blunt ends or overhangs were 
incubated at room temperature for one hour with 1 μM HMO2 in 10 μl reaction buffer. One μl of 
0.1 U/ μl DNaseI (New England Biolabs) was added in presence of DNase I buffer and incubated 
for 1, 2.5 and 5 minutes. Reactions were terminated by adding 2 μl of stop buffer and incubating 
at 37°C for 30 minutes, followed by addition of 1 μl of 10% SDS. Samples were electrophoresed 
on 1% TBE agarose gels. Gels were stained with ethidium bromide. 
Results 
HMO2 Binds Preferentially to Distorted DNA Compared to Linear 
Duplex 
 
While HMO2 has been proposed to interact with a damage-induced histone H2A variant, 
conservation of its Box B HMG-domain predicts direct DNA interaction. To investigate a 
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potential role in DNA interaction, HMO2 was therefore cloned from yeast genomic DNA and 
overexpressed in E. coli. HMO2 was judged to be >95% pure using Coomassie blue stained 
SDS-PAGE gels (Fig. 2.1). Consistent with the presence of the classical Box B HMG domain, 
HMO2 binds both supercoiled and linear DNA (Fig. 2.2A) suggesting non-sequence-specific 
binding as seen for other chromatin-associated HMGB proteins. While the mobility of HMO2-
associated linear DNA is gradually reduced as a function of [HMO2] (Fig. 2.2B), the mobility of 
supercoiled DNA is enhanced at the highest [HMO2] (Fig. 2.2A), suggesting DNA compaction. 
Note also that ethidium bromide staining of HMO2-bound DNA is enhanced compared to free 
DNA, perhaps reflecting a DNA unwinding by HMO2 that promotes dye-binding.  
Like other HMGB proteins, HMO2 can constrain DNA supercoils (Fig. 2.2C).When nicked 
plasmid was incubated with HMO2 in presence of T4 DNA ligase, HMO2 was found to 
introduce supercoils to the relaxed DNA. Electrophoresis in the presence of chloroquine 
indicates the expected introduction of negative supercoils by HMO2 (i.e., a slower migration of 
topoisomers in the presence of chloroquine; data not shown). This is in consensus with other 
HMGB proteins which can supercoil relaxed DNA (31). The ability of HMO2 to introduce 
supercoils is consistent with the DNA compaction seen on interaction with plasmid DNA (Fig. 
2.2A). DNA binding was analyzed further using Electrophoretic Mobility Shift Assays (EMSA). 
HMO2 does not form detectable complex with 50 bp DNA duplex (Fig. 2.3A) most likely 
reflecting that complexes are unstable and dissociate during electrophoresis since association 






Fig.2.1 Purified HMO2 visualized using Coomassie blue-stained 15% SDS-PAGE gel.MW is 
molecular weight in kDa. 












Figure 2.2: Interaction of HMO2 with plasmid DNA. A-B: Agarose gel retardation of 100 ng 
plasmid DNA titrated with HMO2. A: Reactions with supercoiled pGEM5. Lane 1, DNA only, 
lanes 2-7 with 1.0–6.0 μM HMO2. B: Reactions with linearized pGEM5. Lane 1, DNA only, 
lanes 2-6 with 1.0 -5.0 μM HMO2. C: HMO2 supercoils relaxed DNA. Lane 1, 100 ng 
supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. 







Mammalian HMGB was previously shown to bind preferentially to 37 bp DNA containing a pair 
of loops (tandem mismatches) separated by 9 bp of duplex (40). Using the same set of 
mismatches in the context of 50 bp duplex (Table 2.1), HMO2 was seen to form a single stable 
complex (Fig. 2.3D) indicating preferred binding to the looped DNA construct. Notably, 
association with the tandem-loop construct leads to enhanced complex formation compared to 50 
bp DNA with a single  loop (Fig. 2.3B-C), and binding to the 50 bp duplex containing the CT 
loop (in which the sequence of the bottom strand contains a 3'-CT-5' sequence, resulting in 
identical opposing bases; Fig. 2.3C) is more stable than the 50 bp duplex with AA loop (Fig. 
2.3B), perhaps indicating that the sequence of the nucleotides at the loop results in differential 
DNA distortion, which in turn affects HMO2 binding (an interpretation based on reported 
differential dynamic properties of DNA with different base mismatches; e.g., 41), or inherent 
sequence preferences of HMO2. Complex formation was generally more defined in presence of 
detergent as HMO2 self-associates in its absence (not shown); we therefore also had to consider 
the possibility that equilibrium binding conditions include a contribution from monomeric 
HMO2 dissociating from a larger aggregate when diluted from a concentrated stock solution, 
even in the presence of detergent, and we elected not to calculate a binding constant. Such self-
association was also noted for the yeast HMGB homolog HMO1 (31,37,38). With the 37 bp 
DNA duplex with tandem loops, HMO2 forms an unstable but detectable complex, while no 
preferred binding was seen to 37 bp DNA with a single nick, gap or overhang (consistent with 
the observation that HMO2 binds preferentially to 50 bp DNA with two separate lesions; (data 









Table2.1- A: Sequence of 50 bp duplex. B: 50 bp duplex with two tandem mismatches (in 
bold).C: 50 bp duplex with single mismatch composed of CT. D: 50 bp duplex with single 
mismatch composed of AA. E: Sequences of strands for the four-way junctions (39). 
 
A: 5′ TTCAATCCCCGTCTGTCCCCCGATCCCCTGCTCGTAGGCGTGCTTGACCG 3′ 
   3′ AAGTTAGGGGCAGACAGGGGGCTAGGGGACGAGCATCCGCACGAACTGGC 5′ 
 
B: 5′ ACAGTGGAGTAGGCTACACCTACTCTTTGTAAGAATTTTGCAAAAAGTAC 3′ 
   3′ TGTCACCTCATCCGATGTGCTTGAGAAACAAACTTAAAACGTTTTTCATG 5′ 
 
C: 5′ ACAGTGGAGTAGGCTACACCTACTCTTTGTAAGAATTTTGCAAAAAGTAC 3′ 
   3′ TGTCACCTCATCCGATGTGCTTGAGAAACATTCTTAAAACGTTTTTCATG 5′ 
 
D: 5′ ACAGTGGAGTAGGCTACACCTACTCTTTGTAAGAATTTTGCAAAAAGTAC 3′ 
   3′ TGTCACCTCATCCGATGTGGATGAGAAACAAACTTAAAACGTTTTTCATG 5′ 
    
E: strand 1, 5′ CCCTATAACCCCTGCATTGAATTCCAGTCTGATAA 3′ 
   strand 2, 5′ GTAGTCGTGATAGGTGCAGGGGTTATAGGG 3′ 
   strand 3, 5′ AACAGTAGCTCTTATTCGAGCTCGCGCCCTATCACGACTA 3′ 











Figure 2.3: HMO2 binds preferentially to DNA with pairs of tandem mismatches. A: EMSA of 
50 bp DNA duplex and increasing concentrations of HMO2. B-C: EMSA of 50 bp DNA duplex 
with a single loop (tandem mismatches) and increasing concentrations of HMO2; B, loop 
composed of opposing AA nucleotides, C, loop composed of opposing CT nucleotides. D: 
EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and 
increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2-8, reactions with 
50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. E: EMSA of four way junction DNA. Lane 
1, 5 fmoles of four way junction only. Lanes 2-10, reactions with 50, 100, 500, 1000, 2000, 
3000, 4000, 5000 and 6000 nM HMO2.  
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Evidently, HMO2 binds preferentially to DNA with a pair of lesions, but only in duplex 
DNA of sufficient length. On removal of the N-terminal His6-tag, no difference was observed in 
DNA binding indicating that the presence of the His6-tag does not interfere with DNA binding 
(data not shown).  
 HMGB proteins generally also have higher affinity for four-way junction DNA compared 
to perfect duplex DNA, provided the absence of Mg
2+
, which would induce a disfavored stacked 
X conformation of the junctions (42-44). HMO2, however, has only a modest preference for the 
four-way DNA junctions in absence of Mg
2+
 (Fig. 2.3E) compared to perfect duplex DNA and 
forms complex comparable to that seen with DNA containing a single lesion. 
 To ascertain whether HMO2 binds preferentially to supercoiled DNA, a competition 
assay was performed by incubating 5 fmoles 50 bp looped DNA and 4 μM HMO2, following 
which 0.5-50 fmoles of supercoiled or linearized pGEM5 was added to the reaction. Evidently, 
supercoiled DNA competes more efficiently (Fig. 2.4); HMO2 forms a distinct complex with the 
looped DNA while supercoiled DNA competes as indicated by disappearance of the preformed 
complex. The linearized DNA does not compete at equivalent concentrations whether the DNA 
has 5'-overhangs, 3'-overhangs or blunt ends (Fig. 2.4B and data not shown; note that the 
concentration of free DNA ends is at most 10 nM, well below the concentration of HMO2, while 
the concentration of internal sites would be more than two orders-of-magnitude higher, assuming 
a 20 bp site size). This suggests that HMO2 binds to supercoiled DNA with higher affinity 
compared to linearized DNA. Taken together, our data indicate that HMO2 resembles 
mammalian HMGB proteins in its preferred binding to supercoiled DNA or DNA with tandem 
mismatches, but that it distinguishes itself by its requirement for a longer DNA duplex and its 





Figure 2.4: HMO2 binds preferentially to supercoiled DNA compared to linear DNA. A: 
Reactions with 5 fmoles of 50 bp looped DNA and 4 µM HMO2. Lanes 1, DNA only, lanes 2, 
50 bp looped DNA and 4 µM HMO2. Lanes 3-11 with 0.5–50 fmoles supercoiled pGEM5. B: 












 HMO2 Binds DNA Ends 
HMGB proteins have been reported to promote DNA end-joining in vitro (26,27). The in 
vivo correlate would be that during double strand break repair, HMGB might bring two DNA 
ends in closer proximity in preparation for either homologous recombination or non-homologous 
end-joining. HMO2, however, did not promote the formation of end-joined products in the 
presence of T4 DNA ligase. Instead, HMO2 prevented end-joining of DNA with a 5'-TA 
extension (Fig. 2.5A) or DNA with blunt ends (Fig. 2.5 B). In Fig. 2.5A-B, lanes 2 show 100 ng 
(~4 nM) linearized DNA ligated in presence of T4 DNA ligase. But in presence of HMO2 (0.1 – 
4 µM; lanes 3-8) there are few if any end-joined products. By comparison, 100 ng plasmid DNA 
(~2 nM) may be efficiently ligated in the presence of mammalian HMGB1, with optimal ligation 
efficiency seen on addition of ~1 µM HMGB1 (26). Notably, lanes 9 suggest that the DNA is 
resistant to exonuclease III digestion in the presence of HMO2 and T4 DNA ligase. The failure 
to observe ligation products in presence of HMO2 as well as the inability of exonuclease III to 
digest the DNA suggests that HMO2 may be binding to the ends of the DNA duplex to prevent 
access to both T4 DNA ligase and exonuclease III. Also note that failure to join DNA ends is not 
due to HMO2 merely interacting with the ligase to prevent its activity, as evidenced by the 
activity of T4 DNA ligase on an internal DNA nick in the presence of HMO2 (Fig. 2.2C). To 
examine further a potential DNA end-binding by HMO2, DNA with a 2-nt 5'-TA extension or 
blunt ends (Fig. 2.6A) and DNA with a 2-nt 3'-AT extension (Fig. 2.6B) was treated with 






Figure 2.5: HMO2 prevents ligation of DNA by T4 DNA ligase. A: DNA with overhangs (5'-TA 
extensions). B: DNA with blunt ends. Lanes 1, 100 ng of DNA (~4 nM, corresponding to ~8 nM 
DNA ends). Lanes 2, DNA and T4 DNA ligase. Lanes 3-8, DNA, T4 DNA ligase with 100, 500, 
1000, 2000, 3000 and 4000 nM HMO2. Lanes 9, DNA, T4 DNA ligase, 4000 nM HMO2 and 








Exonuclease III reactions are terminated with SDS, and a control in which HMO2 is incubated 
with DNA in absence of exonuclease III is included (lanes 3); in the latter reactions, the original 
DNA is quantitatively recovered upon treatment with SDS, indicating complete disruption of the 
HMO2-DNA complex, which would otherwise be manifest as a mobility shift as seen in Fig. 2.2. 
Fig. 2.6A, lanes 2 and 6 and Fig. 2.6B, lane 2, shows DNA with 5' overhangs, blunt ends and 3' 
overhangs digested extensively by exonuclease III. But in presence of HMO2, the DNA is 
protected (Fig. 2.6A, lanes 4 and 8; panel B, lane 4). Since HMO2 obviously prevents the 
formation of partial digestion products, as it prevents the more extensive digestion seen on 
prolonged incubation with exonuclease III, we elected to show only the time-point at which 
exonuclease III has digested unprotected DNA to such an extent that no individual bands are 
discernible. These data suggest that HMO2 may be binding to both DNA with 5' and 3' 
overhangs or blunt ends and preventing exonuclease III from accessing the ends. If HMO2 binds 
stably to DNA ends, preventing access of both T4 DNA ligase and exonuclease III, then the 
expectation would have been for stable complex formation with 50 bp DNA duplex. This is not 
observed (Fig. 2.3A). Further, we do not observe protection of 50 bp DNA from exonuclease III-
digestion in the presence of HMO2 (data not shown). We therefore considered that the 50 bp 
DNA might be too short to accommodate HMO2 stably at both ends simultaneously. To address 
this question, plasmid DNA was digested with assorted enzymes to yield fragments of different 










Figure 2.6: HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. A: 
Lanes 1-4 and 5-8, DNA with 2-nt 5'-TA extensions (~4 nM) and blunt ends (~2 nM), 
respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 
6, DNA treated with exonuclease III for one hour. Lanes 4 and 8, DNA with 1000 nM HMO2 
incubated with exonuclease III for one hour. B: DNA with 2-nt 3'-AT extensions (~4 nM). Lane 
1, DNA only. Lane 2, DNA treated with exonuclease III for one hour. Lane 3, DNA with 2-nt 3' 









However, when incubated with HMO2 and exonuclease III, no protection is observed 
(Fig. 2.7A, lane 4), while DNA with 5'-TA extension is protected from exonucleolytic digestion 
(lane 8). Consistent with the inability of HMO2 to protect DNA with BspHI-generated 5'-
overhangs, such DNA may be re-ligated in presence of T4 DNA ligase (Fig. 2.7B, lane 3; lanes 1 
and 2 contain DNA without and with T4 DNA ligase, respectively). That ligation products 
obtained in the presence of HMO2 migrate differently compared to those created in its absence 
may suggest either that HMO2 still binds with sufficient affinity to the 5'-CATG overhangs to 
compete with ligase for binding or that binding to internal sites results in a DNA conformation 
that favors formation of a different population of ligation products. Since DNA with 5'-AATT 
extensions is efficiently protected (Fig. 2.7C), our data suggest that it is the sequence of the 
overhangs that affects HMO2 binding. The differential protection of DNA of comparable length, 
but with distinct sequence of the single-stranded overhang, clearly indicates that HMO2 
recognizes specific features of DNA ends. 
To determine the DNA length required for efficient protection by HMO2, we therefore 
used enzymes that produce blunt ends or A+T-containing overhangs. A pCDNA3-derivative 
when linearized with ApoI produces the following sizes of DNA, 127, 187, 811, 848, 1444, 1475 
and 2277 base pairs. Fig. 2.7C, lane 4 shows that HMO2 could efficiently protect 811, 848, 
1444, 1475 and 2277 base pairs but was unable to protect 127 and 187 bp DNA, indicating that a 
suitable size of the DNA is important for HMO2 in order to protect it from exonucleolytic 
cleavage. Consistent with this observation, HMO2 was able to protect 339, 692 and 713 bp 
fragments of pRAD1 linearized with DraI (data not shown). This suggests that not only the size 
of the DNA but also the sequence of the DNA overhang is important for HMO2 to bind and 
protect the DNA.  
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The failure to protect short DNA from exonuclease III digestion, even if single-stranded 
overhangs are otherwise compatible with HMO2-binding, predicts that such duplexes should be 
ligatable in presence of HMO2. We therefore performed an end-joining assay using 105 bp DNA 
with 5'-AATT overhangs. Fig. 2.7D shows that HMO2 promotes DNA dimer formation in 
presence of T4 DNA ligase (lanes 3-5). Similar reactions with Bacillus subtilis HU indicate 
formation of monomer circle, as evidenced by its protection from exonuclease III digestion 
(lanes 6 and 7). Lane 8 indicates that ligation products with 105 bp obtained in presence of 
HMO2 cannot be protected from exonuclease III. This experiment not only confirms the inability 
of HMO2 to associate with the ends of short DNA in a manner that prevents access to ligase and 
exonuclease III, but it also reveals that HMO2 does not promote cyclization of short DNA. 
Whether this reflects an inability of HMO2 to bend DNA, the association of several HMO2 
protomers causing out-of-phase bending, or preferred binding to DNA ends remains to be 
determined. To rule out the possibility that HMO2 may coat or compact the entire DNA, thereby 
rendering the majority of the DNA resistant to exonuclease digestion, we assessed whether 
HMO2-DNA complexes are also resistant to endonucleolytic digestion. 
Supercoiled DNA or linear DNA with overhangs or blunt ends were treated with DNase 
I. Fig. 2.8, lanes 2, 8 and 14 show DNA treated with DNaseI wherein the DNA is digested 
extensively. In presence of HMO2, DNaseI is likewise able to digest the DNA (lanes 4-6, 10-12 
and 16-18). The inability of HMO2 to attenuate endonucleolytic digestion is consistent with the 
interpretation that protection against exonuclease III-mediated digestion is due to end-binding by 






Figure 2.7: DNA protection by HMO2 depends on DNA length and sequence of DNA 
overhangs. A: DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1-4, 
DNA with 5'-CATG extensions (~2 nM), lanes 5-8, DNA with 5'-TA extensions (~4 nM). Lanes 
1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for one hour. Lanes 3 and 
7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with 
exonuclease III for one hour. Note in lane 8 the appearance of a product with lower mobility. 
Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1-4. B: Ligation of 
DNA with 5'-CATG extension (~2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. 
Lane 3, DNA, T4 DNA ligase and 2.5 µM HMO2. C: Length dependence of DNA protection by 
HMO2. Lane 1, DNA with 4-nt 5'overhangs. Lane 2, DNA treated with exonuclease III for one 
hour. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease 
III for one hour. D: HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 
femtomoles of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3-5, 105 bp DNA, 
T4 DNA ligase and 100, 250 and 500 nM HMO2.  Lane 6, 105 bp DNA, T4 DNA ligase and 100 
nM Bacillus subtilis HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM Bacillus subtilis 





binding to DNA ends that is characteristic of HMO2 is unique and not a general property of the 
yeast HMGB proteins, we performed the equivalent assays with HMO1.  
 As shown in Fig. 2.9, properties of HMO1 are more akin to those of mammalian 
HMGB1; it does promote the association of DNA ends in the presence of DNA ligase (Fig. 
2.9A), but it either does not bind to DNA ends or does so only transiently to allow efficient 
access to exonuclease III, as evidenced by its failure to protect linearized pGEM5 with 2-nt 5´ 
overhangs from exonucleolytic cleavage (Fig. 2.9B, lanes 4-6). 
Discussion 
Preferential Binding to Distorted DNA 
The occluded DNA site size for an HMG domain is ~10 bp (19-23). Since HMO2 has 
two domains, Box A and Box B, it would be predicted to require at least a 20 bp DNA site; 
indeed, the yeast HMGB homolog HMO1, which also features two HMG-like domains, binds 
poorly to 18 bp DNA, but with significantly higher affinity to 26 bp DNA (37). However, our 
data suggest that HMO2 binds only weakly to 37 bp DNA with loops (data not shown) and with 
much greater affinity to 50 bp looped DNA (Fig. 2.3). For the Box B domain, which has high 
homology to mammalian HMGB proteins, interaction with a 10 bp site is a strong prediction. 
Although the Box A domain differs from consensus HMG sequences, its similarity to the HMO1 
Box A domain, which also differs from consensus sequences, yet interacts with an ~10 bp site, 
likewise predicts an ~10 bp site. Based on these assumptions about the site sizes for Box A and 
Box B, a 50 bp DNA construct would be of sufficient length to accommodate a dimer; this 







Figure 2.8: HMO2 does not protect supercoiled or linearized DNA from endonucleolytic 
cleavage. Lane 1-6, 7-12 and 13-18, supercoiled DNA, DNA with overhangs and DNA with 
blunt ends, respectively (~4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 
1000 nM HMO2.  Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 minutes. Lanes 4, 5 and 
6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 minutes. Lanes 
10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 
minutes. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I 








Figure 2.9. HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic 
cleavage. A: HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5' overhang in presence 
of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3-5, 
DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. B: HMO1 is unable to 
protect DNA with 2-nt 5' overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, 
DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4-6, DNA, exonuclease III, 








dimer, as the loops may potentially impose a constraint, such as preferred binding to the 4-nt 
loop by only one of the two protein domains. 
 HMGB proteins have been previously shown to bind DNA with loops (40,45). The 
binding preference for DNA with flexure points is a functional correlate of the DNA bend 
introduced on interaction with an HMG domain, and the prediction is that HMO2 likewise bends 
its DNA site. HMGB proteins also bind preferably to four-way DNA junctions (42-44); while 
HMO2 does bind four-way DNA junctions in preference to a linear DNA duplex (compare Fig. 
2.3A and 2.3E), the preference is modest. For mammalian HMGB1, binding to four-way DNA 
junctions is mediated by the Box A domain (44). This selectivity arises from using a 
hydrophobic residue from helix II of the HMG fold as a bending wedge; the greater preference 
for distorted DNA is due to stacking of this residue on an exposed base pair. In contrast, 
mammalian HMGB1 Box B has bending wedges in both helices I and II of the HMG fold and is 
primarily responsible for DNA bending, whereas its affinity for distorted DNA is only modestly 
higher than that for perfect duplex DNA. By comparison, HMO2 is also predicted to feature a 
bending wedge (Leu) in helix II of its Box A domain, suggesting that this domain contributes the 
binding preference for distorted DNA. For HMO2 Box B, a leucine in helix I would be predicted 
to be the DNA intercalating residue.  
Like other HMGB proteins, HMO2 binds preferentially to supercoiled DNA compared to 
linear DNA (Figs. 2.2 and 2.4). The DNA-protein complex with highest [HMO2] migrates faster 
in the gel (Fig. 2.2, lanes 6 and 7), suggesting that HMO2 might play a role in DNA compaction. 
This observation is consistent with the ability of HMO2 to introduce supercoils and with the 
enhanced staining of HMO2-bound DNA by ethidium bromide that may also reflect DNA 
unwinding by HMO2. While nuclear HMGB proteins have not been shown to compact DNA in 
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vitro as determined by changes in electrophoretic mobility, Abf2p, a protein closely related to the 
HMG family, has been shown to compact mitochondrial DNA (46). Long-range DNA looping 




Consistent with its preferred binding to negatively supercoiled DNA, HMO2 produces 
DNA supercoils, due either to DNA underwinding or out-of-plane bending. And as noted above, 
its preferred binding to DNA loops likely reflects the energetic advantage to bending DNA with 
flexible joints. In these interactions, HMO2 emulates properties of mammalian HMGB 
homologs. What is unique about HMO2 is its remarkable ability to protect certain DNA 
constructs from exonucleolytic cleavage and to prevent their end-joining in presence of T4 DNA 
ligase, suggesting preferred binding to these DNA ends. DNA with blunt ends is protected 
efficiently, while in case of DNA with overhangs, the sequence of the single stranded overhang 
significantly affects HMO2 binding (Fig. 2.6A-B, Fig. 2.7A). Considering the preferred binding 
of HMO2 to distorted DNA sites, its interaction with DNA ends may likewise be a manifestation 
of preferred binding to more deformable duplex regions. Mammalian HMGB1 has been reported 
to bind DNA ends, but not to protect DNA ends from exonuclease III, perhaps reflecting a more 
dynamic association with the DNA ends (26). The ability of HMO2 to associate more stably with 
DNA ends is perhaps attributable to the divergent Box A domain which bears little resemblance 
to mammalian Box A.  
It is also evident that HMO2 requires DNA of a suitable length to bind and protect (Fig. 
2.7C). Since HMO2 forms stable complex with plasmid DNA, but not with 50 bp perfect duplex, 
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and since it appears to bind only as a dimer to 50 bp looped DNA, complex stability is likely a 
consequence of both DNA structure and protein-protein interactions. Such interactions are likely 
the reason for protection only of DNA long enough for assembly of several protomers at each 
DNA end. Self-association was also reported for the yeast HMGB homolog HMO1 as well as for 
mammalian HMGB1, for which residues in the box B domain critical for its ability to stimulate 
DNA end-joining were also important for box B self-association on supercoiled DNA and the 
formation of large nucleoprotein complexes (26,31,37).
 
If HMO2 were to protect DNA from exonuclease III digestion largely by occluding 
essentially the entire DNA, except for a limited number of base pairs at the ends, then protection 
from endonuclease digestion might also be seen. However, no such protection is observed (Fig. 
2.8). For this interpretation to be considered, one would also expect that all DNA fragments, 
regardless of sequence of the DNA overhangs, would be protected comparably. This is also not 
observed, as evidenced by the failure of HMO2 to protect DNA with C- or G-containing 
overhangs (Fig. 2.7A-B). We also note that ligation at an internal nick occurs in the presence of 
HMO2 (Fig. 2.2C). For HMO2 to bend internal sites, thereby restricting access to exonuclease 
III and DNA ligase is likewise unlikely; first, attenuated access to endonuclease would again be 
expected, as would protection of DNA fragments regardless of sequence of DNA overhangs. If 
significant out-of-phase bending occurred upon HMO2 binding, this could stiffen DNA and 
prevent net DNA bending, resulting in preferential generation of linear ligation products in 
preference to circular products, an effect likely to be most pronounced using shorter DNA 
fragments as opposed to plasmid DNA. Indeed, facilitated cyclization of short DNA fragments in 
presence of a DNA-bending protein is commonly used as an assay for DNA bending, without 
internal DNA bends restricting access of DNA ligase to DNA ends (27,37). In-phase bending 
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might lead to compaction; such compacted DNA may be produced by both HMGB homologs 
and the bacterial histone-like HU proteins, again without restricting access of DNA ends to DNA 
ligase (e.g., 48). Based on these observations and considerations, we therefore conclude that 
HMO2 exerts its protection against exonuclease III by binding to the DNA ends. 
If DNA with complementary overhangs were to anneal, a duplex with nicks would be 
produced. However, it can also be ruled out that HMO2 merely binds preferentially to such 
nicked DNA constructs to prevent their ligation, as short DNA with equivalent overhangs may 
be ligated (Fig. 2.7D). Nicked plasmid DNA may likewise be ligated in the presence of HMO2 
(Fig. 2.2C). Indeed, the enhanced ligation of 105 bp DNA in the presence of HMO2 suggests that 
HMO2 may also bind the ends of the shorter DNA, albeit less stably, as reflected in its inability 
to protect such duplexes from exonucleolytic digestion. That HMO2 promotes DNA end-joining 
in the presence of DNA ligase may also be related to the occasional appearance of more slowly 
migrating DNA species following incubation of linear DNA with both HMO2 and exonuclease 
III (Fig. 2.7A, lane 8); since these reactions are deproteinized and no ligase is present, we 
surmise that long single-stranded overhangs generated by exonuclease may invade a 
complementary duplex in presence of HMO2 to generate a merged structure that is stable to the 
subsequent manipulations. This possibility is currently under investigation. 
Recently, HMO2 was reported to be a part of the ATP-dependent chromatin remodeling 
complex INO80 and to be important for recruitment of the INO80 complex to a DSB (3). Arrival 
of the INO80 complex is predicted to be a part of the early response to DSB formation. In both 
mammalian and yeast cells, a complex containing the Ku heterodimer and DNA ligase is capable 
of rejoining DNA double strand breaks with compatible ends via non-homologous end-joining, 
while DNA with damaged ends requires additional factors (2,4). Further, non-homologous end-
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joining and homologous recombination events interfere with each other; for example, a Rad51 
filament forms on single-stranded DNA in preparation for homologous recombination and 
impedes non-homologous end-joining (49). It is conceivable; therefore, that HMO2, in addition 
to its role in INO80 recruitment, also contributes to the protection of DNA ends that is essential 
to preserve the genetic information before DSB repair can be completed. In its complex with 
INO80 components, HMO2 was reported to interact with phosphorylated histone H2A, 
indicating that it is not buried in the complex, but accessible for interaction with chromatin. It is 
therefore likely that it would also be accessible for binding to naked DNA. The preferred binding 
to DNA with blunt ends or with A+T-containing overhangs may indicate differential functions 
depending on the type of DNA ends and the DNA repair pathway; for example, yeast Rad51 
binds more slowly to single-stranded DNA with AT dinucleotide repeats compared to C- or G-
containing dinucleotide repeats (50), perhaps requiring accessory proteins to protect such A+T-
rich sequences. 
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INDIVIDUAL DOMAINS OF HMO2 HAVE DIFFERENT PREFERENCES 
FOR VARIOUS DNA SUBSTRATES  
 
Introduction 
High Mobility Group Proteins (HMGB) are architectural proteins found ubiquitously in 
eukaryotes where they play varied roles in DNA-dependent processes such as DNA 
recombination, transcription and repair (1-6). HMGB proteins usually contain two DNA-binding 
HMG domains, named Box A and Box B, followed by an acidic C-terminal tail, and they bind to 
DNA in a non-sequence specific manner (2, 7, 8). Each HMG box is composed of ~80 amino 
acids, which adopt an L-shaped fold created from three α-helices (9-12). DNA binding occurs 
through the minor groove of the DNA by partial intercalation of hydrophobic amino acid 
residues (1, 2, 9, 12). As for other DNA-bending proteins, binding to DNA with unusual 
structures is energetically favorable, and HMGB proteins bind preferentially to distorted DNA 
such as cis-platin [cis-diaminedichloroplatinum (II)] modified DNA and four-way junctions (13-
15). HMGB proteins have also been reported to bind to DNA with nicks, loops, gaps and 
overhangs (16, 17). 
Of several HMGB proteins in Saccharomyces cerevisiae, HMO1 and HMO2 contain a 
Box B domain that resembles that of mammalian HMGB proteins and a Box A domain with only 
limited similarity. For HMO1, Box B contributes primarily to DNA-binding affinity, while the 
Box A domain is necessary for bending of duplex DNA and the unique lysine-rich C-terminal 
tail mediates in-phase DNA bending (15, 17, 18). Numerous functions for HMO1 have been 
reported, including roles in rDNA transcription and coordination of ribosomal protein and rRNA 
production in response to signaling by the target of rapamycin (TOR) pathway (reviewed in 
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(19)). In contrast, the only reported function of HMO2 is its role in directing the INO80 
chromatin remodeling complex to double strand breaks (DSBs) (20-22). Recently, we reported 
that HMO2 binds to DNA ends and protects them from exonuclease III digestion, consistent with 
a role in DSB repair (23).    
Here we define the roles of the tandem HMG boxes, Box A and Box B in binding to 
various DNA substrates, such as DNA with loops, four-way junctions and DNA with stem-loop 
features. The Box A domain from mammalian HMGB homologs has been previously shown to 
contribute to DNA bending (17) and to bind to four-way junctions (11, 16); HMO2 Box A, like 
the mammalian HMGBs, binds to the Holliday junctions. HMGB proteins have also been shown 
to participate in DNA end joining (24-26). Here we try to elucidate the roles of HMO2 Box A 
and Box B in DNA end-joining and the role of Box A to protect DNA ends.  
Materials and Methods 
Cloning, Overexpression and Purification of HMO2 Variants and 
HMO2 Fused with Gst Tag 
 
Full-length HMO2 was prepared as described (23). HMO2-BoxA was obtained using 
pET14b-HMO2 as template (carrying the gene encoding full-length HMO2) and using primers 
that introduce a stop codon at threonine 81 using forward primer 5′-
GAAAATCTAAATAAAAAAGACACAAAG-3′ with stop codon underlined and reverse primer 
5′-GAAATGGCTTCGTCAATAG-3′ to obtain HMO2-Box A. The construct was transformed 
into E.coli Top10 competent cells. The correct HMO2-BoxA construct was determined by DNA 
sequencing. HMO2-BoxAB was amplified from yeast genomic DNA using forward primer 5′-
CACCATGTCAGTTGAAGAAAAAAAGCG-3′ which introduces TOPO recognition sequence 
(underlined) and a reverse primer 5′-
GATATCTTTTAATTATATATTTCCATTTCCATCTGG3′ that introduces a stop codon in 
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place of amino acid lysine 158. Similarly, genes encoding HMO2-BoxB and HMO2-BoxBC 
were amplified from yeast genomic DNA using forward primer 5′-CACCATGCCCAAGAGGC-
3′, which introduces TOPO recognition sequence (underlined), and reverse primers 5′-
GATATCTTTTAATTATATATTTCCATTTCCATCTGG-3′ (that introduces a stop codon in 
place of residue lysine 158) and 5′-CGTCTTACCATATGTTCAAAGAA-3′, respectively. The 
PCR products were cloned into the expression vector pET100/D-TOPO (Invitrogen), which 
introduces a 6X-histidine tag at the amino terminus. Plasmids carrying HMO2-BoxA, HMO2-
BoxAB, HMO2-BoxB and HMO2-BoxBC were transformed into E. coli Rosetta Blue and 
expression was induced by addition of 1 mM IPTG at A600 of 0.2 and induction was carried out 
for 4 hours at 37ºC. Cells were pelleted and resuspended in lysis buffer pH 7.5 (50 mM 
NaxHyPO4, 300 mM NaCl, 10 mM imidazole, 20% glycerol for HMO2-BoxA and 10%  glycerol 
for HMO2-BoxB and HMO2-BoxBC, 1 mM 2-mercaptoethanol and 1 mM 
phenylmethylsulfonyl fluoride (PMSF)). Cells were disrupted by sonication and the nucleic acids 
were digested by addition of 2 µl of 2000 U/ml of DNaseI (New England Biolabs) and incubated 
on ice for 1 h and centrifuged at 6000 x g for 20 min. For HMO2-BoxA, the cell lysate was 
incubated with the nickel resin for 1 hr on ice and then the flow through from the nickel column 
was collected and then incubated on ice for 1 hr with cobalt beads previously equilibrated with 
the lysis buffer. The nickel beads for HMO2-BoxB and HMO2-BoxBC and the cobalt beads for 
HMO2-BoxA were washed with wash buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 20 mM 
imidazole, 20% glycerol for HMO2-BoxA and 10% glycerol for HMO2-BoxB and HMO2-
BoxBC, 1 mM 2-mercaptoethanol and 1 mM PMSF). Proteins were eluted by gravity flow using 
elution buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl with 250 mM imidazole and 20% 
glycerol for HMO2-BoxA and 100 mM imidazole and 10% glycerol for HMO2-BoxB and 
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HMO2-BoxBC, 1 mM 2-mercaptoethanol and 1 mM PMSF). For HMO2-BoxAB the cell lysate 
was treated with 60% ammonium sulfate. The pellet from the ammonium sulfate precipitation 
was dissolved and dialysed overnight at 4°C against HA buffer pH 7.5 (20 mM Tris, 50 mM 
KCl, 10% glycerol, 1 mM 2-mercaptoethanol and 1 mM PMSF). The dialysate was loaded on 
DEAE column and protein was eluted with a 96 ml linear gradient from 50 mM KCl (HA buffer) 
to 1 M KCl. The fractions collected were dialysed overnight at 4°C with HA buffer pH 6.0 and 
passed through CM-sepharose and protein was eluted with 96 ml linear gradient from 50 mM 
KCl (HA buffer) to 1 M KCl. The peak fractions were pooled and dialysed overnight at 4°C 
against HA buffer pH 7.5. The dialysate was passed through hydroxyl-apatite column and the 
purified protein was obtained in the flow through and first wash. Purified proteins were 
quantitated using Coomassie blue stained SDS- PAGE gels using bovine serum albumin as 
standard. 
To generate HMO2 fused with Gst tag at the N-terminal end, HMO2 was amplified from 
yeast genomic DNA using the forward primer 5′ CACAGAATTCATGTCAGTTGAA 3′ 
wherein EcoRI is underlined and the reverse primer 5′ CATTAGCAGCTCGAGGA 3′ wherein 
XhoI is underlined.  The PCR product was cloned in plasmid pGEX-4T between restriction sites 
EcoRI and XhoI and transformed in E. coli Top10 competent cells. The Gst-HMO2 was 
overexpressed in E. coli Rosetta Blue competent cells using 1 mM IPTG for 4 h. Cells were 
pelleted and then resuspended in lysis buffer pH 7.2 (10 mM KxHyPO4, 150 mM NaCl, 1 mM 2-
mercaptoethanol and 1 mM PMSF. Cells were disrupted by sonication. The nucleic acids were 
digested by adding 2 μl of 2000 U/ml of DNaseI (New England Biolabs) and incubated on ice for 
one hour. To the lysate, 0.01% of Triton X-100 was added and the solution was incubated on ice 
for 1 hour and then centrifuged at 6000xg for 20 min. The lysate was incubated with Glutathione 
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agarose beads for 1 hour on ice. The glutathione agarose beads were equilibrated using lysis 
buffer prior to use. The beads were washed using lysis buffer pH 7.2. Proteins were eluted by 
gravity flow using elution buffer pH 8.0 (50 mM Tris 150 mM NaCl, 10% glycerol, 1 mM 2-
mercaptoethanol and 1 mM PMSF) supplemented with 5 mg/ml (final concentration) reduced 
glutathione. Pure Gst-HMO2 was quantitated using Coomassie blue stained SDS-PAGE gels 
using bovine serum albumin as standard. 
Electrophoretic Mobility Shift Assay 
Oligonucleotides were purchased (Eurofins MWG Operon) and purified by denaturing 
gel electrophoresis. Electrophoretic Mobility Shift Assays (EMSAs) were performed using 50 bp 
DNA with two 4-nt loops 9 bp apart, 50 bp DNA with a single 4-nt loop, and 50 bp DNA with a 
single 4-nt loop separated from an abasic site by 9 bp of duplex; 4-nt loops were created from 
two consecutive mismatches of identical opposing bases and the abasic site by introducing a 
tetrahydofuran analog in one DNA strand. The two identical opposing bases creating the 
mismatch are CT and AA. In case of the 50 bp construct with the abasic site, it has a CT 
mismatch 9 bp upstream and another mismatch, made of 5′ AG 3′ in top strand and 3′ CT 5′, in 
the bottom strand, which is 7 bp upstream of the CT mismatch. Other substrates used were four-
way DNA junctions, prepared as described (27) and DNA with stem-loop structure (28). The top 
strands were 5′-end labeled with [γ
32
P] ATP using T4 polynucleotide kinase (New England 
Biolabs). Top and bottom strands were annealed by heating at 90°C then slowly cooling to room 
temperature.  
 Reactions contained 5 fmol DNA with varying concentration of HMO2, HMO2-BoxA, 
HMO2-BoxB or HMO2-BoxBC in 10 µl reaction buffer (20 mM Tris pH 8.0, 5 mM NaCl, 0.1 
mM EDTA, 0.1 mM DTT, 0.1% Triton X-100, 0.01% BRIJ 58) and were incubated at room 
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temperature for 1 h. Samples were loaded on 8% polyacrylamide gels (39:1 
acrylamide:bisacrylamide) and electrophoresed using 0.5X TBE (Tris borate EDTA) at 175 V 
for 2 h. Complexes were resolved using Amersham Biosciences Storm Phosphorimager. 
HMO2-HMO2 Interaction 
Protein-protein interaction: One hundred ng of supercoiled DNA was incubated at room 
temperature with different concentrations of HMO2, Gst-HMO2 and equimolar concentration 
mixture of HMO2 and Gst-HMO2 in 10 μl reaction buffer (20 mM Tris pH 8.0, 0.1 M EDTA, 15 
mM NaCl, 0.1 mM DTT and 0.01% BRIJ 58). Complexes were resolved using 1% TBE agarose 
gels using 0.5X TBE buffer (50 mM Tris borate, 1 mM EDTA) and visualized by ethidium 
bromide staining. 
The 50 bp DNA duplex with tandem loops was used for analyzing HMO2-HMO2 
interaction on a short DNA. The top strand was 5' end labeled using T4 polynucleotide kinase 
(New England Biolabs) and [γ
32
P] ATP. Top and bottom strands were annealed by heating at 
90°C and slowly cooling to room temperature. Reactions contained 5 fmoles of DNA substrate 
and varying concentration of HMO2, Gst-HMO2 and equimolar concentration mixture of HMO2 
and Gst-HMO2 in 10 μl reaction buffer (20 mM Tris pH 8.0, 0.1 mM EDTA, 5 mM NaCl, 0.1 
mM DTT, 0.01% BRIJ 58 and 0.1% Triton X-100) and incubated at room temperature for one 
hour. Samples were loaded on a prerun 8% polyacrylamide gel (39:1 acrylamide:bisacrylamide) 
and electrophoresed using 0.5X TBE at 175 volts for 2 hours. Complexes were visualized using 
Amersham Biosciences Storm Phosphorimager. 
End-joining Assay 
Supercoiled pGEM5 was digested with NdeI to obtain DNA with 2-nt 5′ overhang. One 
hundred nanograms of linearized pGEM5 was incubated with varying concentrations of HMO2 
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or its variants and incubated at room temperature for 1 h. To this reaction, 1 µl of 400 U/µl T4 
DNA ligase was added and incubated at room temperature for 1 h. Reactions were treated with 1 
µl of 100 U/µl exonuclease III at room temperature for 1 h. Reactions were terminated using 1 µl 
stop buffer (5 mM EDTA, 1.1% glycerol, and 0.2 mg/ml proteinase K). Samples were 
electrophoresed on 1% agarose gels in 0.5X TBE and visualized by ethidium bromide staining. 
Exonuclease III Protection Assay 
Supercoiled pGEM5 was linearized with NdeI and incubated at room temperature for 1 h 
with varying concentration of HMO2 variants. Control reactions contained 2 µM HMO2. To 
each reaction, 1 µl of 100 U/µl exonuclease III was added and incubated at room temperature for 
1 h. Reactions were terminated using 1 µl of 10% SDS. Samples were electrophoresed on 1% 
agarose gels in 0.5X TBE and visualized using ethidium bromide staining. 
DNA Lyase Activity 
The oligonucleotides for the DNA lyase activity, 50 nt top strand and 50 nt bottom strand 
with uracil at position 19 from the 5′ end was obtained from Eurofins MWG Operon. This 50 bp 
construct also has the CT mismatch 9 bp upstream of the uracil. Seven bp upstream of the CT 
mismatch it also has another mismatch. Below is the DNA sequence with the mismatches 
indicated in bold. 
     5′ ACAGTGGAGTAGGCTACACCTACTCTTTGTAAGAATTTTGCAAAAAGTAC 3′ 
     3′ TGTCACCTCACTCGATGTGCTTGAGAAACATUCTTAAAACGTTTTTCATG 5′ 
 
The top strand was 5′-end labeled with [γ
32
P] ATP using T4 polynucleotide kinase (New 
England Bioloabs) and annealed to the bottom strand. The 50 bp DNA duplex was incubated 
with 1 µl of 5 U/µl of uracil-DNA glycosylase (UDG) at 37°C for 10 min and then phenol 
chloroform extracted and ethanol precipitated. Then 10 nM UDG treated DNA was incubated 
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with various concentrations of HMO2 in a 10 µl reaction in the same reaction buffer as described 
for EMSA, and incubated at room temperature for 1 h. Reactions were terminated using 1 µl 
10% SDS. UDG treated DNA incubated at 90°C for 20 min was used as a control. Samples were 
electrophoresed on 8% denaturing polyacrylamide gels in 0.5X TBE at 600 volts for 1h. 
Complexes were visualized using Amersham Biosciences Storm Phosphorimager. 
Results 
Box A and Box B Have Greater Preference for DNA with Tandem Pair 
of Mismatches than Box BC  
 
In its interaction with plasmid DNA, HMO2 was previously shown to bind preferentially 
to supercoiled compared to linear DNA and to distorted DNA compared to perfect duplex; on a 
50 bp perfect duplex, HMO2 does not form complexes that are stable to electrophoresis, whereas 
DNA with tandem 4-nt loops was seen to be the preferred substrate compared to DNA with a 
single lesion (23). To address the roles of each domain of HMO2 in conferring preferred binding 
to DNA with tandem lesions, several HMO2 variants were created (Fig. 3.1). HMO2-BoxA 
comprises the N-terminal 81 residues, HMO2-BoxAB is truncated for the C-terminal tail, 
HMO2-BoxBC is truncated for the N-terminal Box A domain, and HMO2-BoxB comprises only 
the Box B domain from residues 91-158. HMO2-BoxAB proved nearly insoluble and very prone 
to aggregation and was not analyzed further. Purified HMO2 variants are shown in Fig. 3.1A-B. 
DNA binding was analyzed by EMSA, using 50 bp DNA with tandem lesions (that is, containing 
a pair of 4-nt loops 9 bp apart). Both HMO2-BoxA and HMO2-BoxB bind to 50 bp DNA with 
two 4-nt loops and form a single stable complex (Fig. 3.2A and 3.2B), although HMO2-BoxB 

























Figure 3.1: Domain organization of HMO2. (A) Cartoon showing domain organization of 
HMO2. (B) Purified HMO2-BoxA domain visualised using Coomassie blue-stained 20% SDS-
PAGE gel. Purified HMO2-BoxB and HMO2-BoxBC domains visualised using Coomassie blue-
stained 20% SDS-PAGE gel.(C)  Purified Gst-HMO2 visualized using Coomassie blue-stained 











Also, the complex with HMO2-BoxB migrates slightly faster than that formed with HMO2-
BoxA, which may be attributed to a difference in the modes of binding of the two domains with 
the DNA, such as differences in stoichiometry or DNA bend angles. HMO2-BoxBC also forms a 
complex with this DNA construct (Fig. 3.2C), but the complex migrates much slower than that 
formed with HMO2-BoxA and HMO2-BoxB. The complex formed with HMO2-BoxBC appears 
at lower protein concentrations, but is not very stable to electrophoresis, suggesting that the 
negatively charged C-terminal tail significantly modulates DNA binding by Box B.  
 While full-length HMO2 binds significantly better to DNA with tandem lesions 
compared to DNA with a single 4-nt loop (23), complex formation with isolated HMO2 domains 
is not significantly different with these DNA constructs; on DNA with a single lesion, containing 
the CT loop only, both HMO2-BoxA, HMO2-BoxB, and HMO2-BoxBC form a single complex 
(Fig. 3.2D-F) comparable to that seen with DNA with tandem lesions, except that HMO2-BoxB 
is more prone to forming multiple complexes (Fig. 3.2E), perhaps reflecting that a second lesion 
attenuates a protein accretion otherwise seen in its absence. These data show that both Box A 
and Box B domains contribute to DNA binding, and suggest that the markedly enhanced binding 
to DNA with tandem lesions by full-length HMO2 may be due to an additive effect of each 
domain associating with one DNA lesion. 
Only Box B Binds Preferentially to DNA With an Abasic Site  
Inspired by a recent report indicating that mammalian HMGB proteins play a role in base 
excision repair (29), we explored the ability of each HMO2 domain to bind DNA with an abasic 
site, an intermediate in base excision repair. We used the same 50 bp DNA construct with 
tandem lesions, retaining the CT loop and replacing the AA loop with a single tetrahydrofuran 












Figure 3.2: Interaction of HMO2 domains with DNA containing mismatches. (A), (B) and (C) 
EMSA with 50 bp DNA duplex with two 4-nt loops (composed of identical opposing AA and CT 
nucleotides, respectively) separated by 9 bp of duplex and increasing concentrations of indicated 
HMO2 variants. (A) DNA duplex with tandem 4-nt loops and increasing concentrations of 
HMO2-BoxA. (B) DNA duplex with tandem 4-nt loops and increasing concentrations of HMO2-
BoxB. (C) DNA duplex with tandem 4-nt loops and increasing concentrations of HMO2-BoxBC. 
(D), (E) and (F) EMSA of 50 bp DNA duplex with a single 4-nt loop (tandem mismatches 
composed of opposing CT nucleotides) and increasing concentrations of HMO2 variants. (D) 
DNA with single 4-nt loop and increasing concentration of HMO2-BoxA. (E) DNA with single 
4-nt loop and increasing concentration of HMO2-BoxB. (F) DNA with single 4-nt loop and 
increasing concentration of HMO2-BoxBC.  Lanes 1, reactions with DNA only, lanes 2–8 
reactions with 50, 75, 100, 250, 500, 750, 1000, 2000 and 3000 nM of the indicated HMO2 












The abasic site is placed 9 bp from the CT mismatch. There is also another mismatch present 7 
bp upstream of the CT mismatch. EMSAs show that wild type HMO2 and the Box B do not form 
a stable complex with DNA containing the CT mismatch and the mismatch 7 bp apart (data not 
shown). 
Full-length HMO2 binds well to the DNA construct containing the abasic site, forming a 
single complex (Fig. 3.3A). HMO2-BoxA does not form stable complexes with this construct 
(Fig. 3.3B), however, HMO2-BoxBC binds more stably compared to DNA with single or tandem 
4-nt loops (Fig. 3.3D), and HMO2-BoxB forms multiple complexes with this DNA construct 
(Fig. 3.3C). For both HMO2-boxB and HMO2-BoxBC, a complex of slower mobility (C2) 
appears at lower protein concentrations, possibly reflecting preferred association of two 
protomers. It is also notable that while the presence of two 4-nt loops prevents accretion of 
additional HMO2-BoxB protomers, such association is favored on DNA containing the abasic 
site. Evidently, the differential DNA distortion imposed by tandem mismatches and abasic sites 
significantly affects the binding mode of the HMO2 domains. 
Unlike Mammalian HMGB Protein, HMO2 Does Not Exhibit AP Lyase 
Activity 
  
Recently HMGB1 has been reported to be a co-factor in mammalian base excision repair 
(BER) and to exhibit AP lyase activity (29). Since the full length HMO2 and HMO2-Box B bind 
to DNA with an abasic site Fig. 3.3, we tested if HMO2 has AP lyase activity. In Fig. 3.4, lane 1 
is 50 bp DNA with a uracil at position 19 of the bottom strand, treated with uracil-DNA 
glycosylase (UDG). Lane 2 contains 50 bp DNA treated with UDG and then heated at 90°C for 5 
minutes. On treatment with UDG, the uracil in the DNA is flipped out and cleaved, creating an 
abasic site, which is heat labile and on heat treatment is cleaved, generating a lower molecular 
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weight product. Lanes 3-5 contain 50 bp DNA treated with UDG and increasing concentrations 
of HMO2 and no heat treatment. If HMO2 had AP lyase activity then it would have generated a 
lower molecular weight product as indicated in lane 2. Thus it can be concluded that HMO2 
lacks AP lyase activity. 
           Differential Preferences for Pre-bent DNA  
 While full-length HMO2 does bind four-way junction in preference to perfect duplex, the 
preference is modest (23). To examine the interaction of HMO2 domains with statically 
deformed DNA, we chose two DNA constructs. The first is DNA with a stem- loop feature 
surrounded by 14 and 7 bp duplex regions (Fig. 3.5). Full-length HMO2 binds to this DNA 
construct forming two complexes, but the migration of the complexes is much slower than those 
formed with DNA with 4-nt loop and abasic site and significant complex dissociation 
duringelectrophoresis is evident (Fig. 3.5A). HMO2-BoxA and HMO2-BoxBC do not bind with 
significant preference to stem-loop DNA (Fig.3.5 B and 3.5 D). In contrast, HMO2-Box B forms 
several complexes with this DNA construct (Fig.3.5 C), suggesting that Box B exhibits a binding 
preference for the acidic tail. For mammalian HMGB proteins, the preferred binding to four-way 
junction DNA is conferred by the Box A domain and the presence of Mg
2+ 
, which induces a 
disfavored X conformation, affects binding to four-way junctions (11, 15, 30). For HMO2, Mg
2+
 
does not affect complex formation, and binding to four-way junction DNA is only modestly 
preferred compared to perfect duplex (23). HMO2-BoxA forms multiple discrete complexes 
(Fig. 3.6A), whereas complexes with HMO2-BoxB dissociate during electrophoresis, although 
the entire DNA is eventually bound unlike what is seen for HMO2-Box A. HMO2-BoxBC fails 
to form detectable complex (Fig. 3.6B-C). The presence or absence of Mg
2+
 did not have any 










Figure 3.3: Interaction of HMO2 variants with DNA containing an abasic site. EMSA with 50 bp 
DNA duplex with an abasic site and a 4-nt loop (composed of opposing CT nucleotides) 
separated by 9 bp and increasing concentration of indicated HMO2 variants. (A) HMO2 (B) 
HMO2-BoxA (C) HMO2-BoxB (D) HMO2-BoxBC. Lanes 1, reactions with DNA only, lanes 2–
8, reactions with 50, 75, 100, 250, 500, 750, 1000, 2000 and 3000 nM of indicated HMO2 
variants. Complex (C) and free DNA (F) indicated at the right. The abasic site is placed 9 bp 
from the CT mismatch. There is also another mismatch present 7 bp upstream of the CT 
mismatch. EMSAs with wild type HMO2 and the Box B and the CT mismatch and the mismatch 




















Figure 3.4: Unlike mammalian HMGB protein, HMO2 does not exhibit AP lyase activity. Lane 
1, free DNA. Lane 2, DNA treated with UDG and heat treated. Lanes 3-5, DNA treated with 
UDG and 100, 250 and 500 nM HMO2, respectively, without heat treatment. The uracil is placed 
9 bp from the CT mismatch. There is also another mismatch present 7 bp upstream of the CT 
mismatch. EMSAs with wild type HMO2 and the Box B and the CT mismatch and the mismatch 























Figure 3.5: Interaction of HMO2 variants with stem-loop DNA. EMSA of stem-loop DNA with 
increasing concentrations of indicated HMO2 variant. (A) HMO2 (B) HMO2-BoxA (C) HMO2-
BoxB (D) HMO2-BoxBC. Lanes 1, 5 fmol of stem-loop DNA only. Lanes 2–10, reactions with 
50, 75, 100, 250, 500, 750, 1000, 2000 and 3000 nM of indicated HMO2 variants. Complex (C) 







HMO2-HMO2 Interaction Indicated in Agarose Gel 
Earlier it has been speculated that HMO2 might bind 50 bp DNA duplex as a dimer (23). 
In order to examine protein-protein interaction, HMO2 was fused with a Gst tag at the N-
terminal end. N-terminally his-tagged HMO2 was earlier obtained by cloning HMO2 in pET14b 
with an N-terminal his-tag. The Gst tag is ~26 kDa by itself so it is expected that Gst-HMO2 in 
complex with DNA would migrate slower in a gel than His-HMO2 as his tag is ~3 kDa. Purified 
Gst-HMO2 is shown in fig.3.1. The experiment was performed such that we indicated the 
migration of DNA and his-HMO2 complex and DNA and Gst-HMO2 complex separately and 
also the migration of the complex with DNA and equimolar mixture of his-HMO2 and Gst-
HMO2. In figure 3.7, top panel indicates supercoiled pGEM5 binding with his-HMO2 and Gst-
HMO2, where lanes 2-7 shows complex with DNA and his-HMO2 and lanes 9-14 indicates 
complex with DNA and Gst-HMO2 and lanes 16-21 indicates supercoiled pGEM5 with 
equimolar concentrations of his-HMO2 and Gst-HMO2, shows DNA further retardation of 
complex as compared to lanes 2-7. On the bottom panel , Figure 3.7 (A) indicates 50 bp DNA 
with tandem pair of mismatches and his-HMO2, (B) indicates 50 bp DNA with tandem pair of 
mismatches and his-HMO2, and (C) indicates 50 bp DNA with tandem pair of mismatches and 
equimolar concentration of his-HMO2 and gst-HMO2. It is interesting to note that in this case 
there is no difference in the migration of the complexes in the three cases, although Gst-HMO2 
is almost double the molecular weight of his-HMO2. But there was a difference in migration of 




Figure 3.6: Binding of HMO2 domains to four-way junction DNA. EMSA of four-way junction 
DNA titrated with the indicated HMO2 variant. Lanes 1, 5 fmol of four way junction only. Lanes 
2–10, reactions with 50, 75, 100, 250, 500, 750, 1000, 2000 and 3000 nM protein. Free DNA (F) 




















Figure 3.7: HMO2-HMO2 interaction using His-tag HMO2 and Gst-HMO2 and equimolar 
mixture of His-HMO2 and Gst-HMO2 and 50 ng of supercoiled pGEM5.Top panel with agarose 
gel. Lanes 1, 8 and 15 reaction with free  DNA only, lanes 2-7 with 250, 500, 750, 1000, 2000, 
3000 nM His-HMO2 and lanes 9-14 with 250, 500, 750, 1000, 2000 and 3000 nM Gst-HMO2 
and lanes 16-21 with  250, 500, 750, 1000, 2000 and 3000 nM equimolar mixture of His-HMO2 
and Gst-HMO2. Bottom panel (A), (B) and (C) EMSA with 50 bp DNA duplex with two 4-nt 
loops (composed of identical opposing AA and CT nucleotides, respectively) separated by 9 bp 
of duplex and increasing concentrations of indicated His-HMO2, Gst-HMO2 and equimolar 
concentrations of His-HMO2 and Gst-HMO2 respectively. Lanes 1, reactions with DNA only, 
lanes 2–1reactions with 100, 250, 500, 750, 1000, 2000,  3000, 4000 and 5000 nM of the 




This could be due to electrophoretic gel conditions and also in case of 50 bp DNA duplex with 
tandem pair of mismatches, there could be a possibility of presence of other complexes in 
solution, but under electrophoretic conditions only the most stable complex is retained. 
Box A Confers on HMO2 the Ability to Protect DNA Ends 
 HMGB proteins have been reported to promote DNA end-joining in presence of DNA 
ligase (24, 26). In contrast, we have shown that full-length HMO2 binds DNA ends and prevents 
DNA end-joining (23). Incubating linearized pGEM5 with low concentrations of T4 DNA ligase 
yields a modest level of ligated product (Fig. 3.8A-B, lanes 2). Neither HMO2-BoxA, nor 
HMO2-BoxB enhance DNA end-joining, nor do they prevent end-joining at lower 
concentrations (Fig.3.8 A-B, lanes 3-7; 10-100 nM). At higher protein concentrations, 
disappearance of the DNA multimer indicates prevention of DNA end- joining by both HMO2-
BoxA and HMO2-BoxB. Treating reactions containing DNA, T4 DNA ligase, and either HMO2-
BoxA or HMO2-BoxB exonuclease III shows that HMO2-BoxA prevents DNA degradation 
(Fig. 3.8A, lane 13), whereas HMO2-BoxB is unable to do so (Fig. 3.8B, lane 14). 
To determine further the ability of HMO2 domains to bind DNA ends, linearized pGEM5 was 
digested with exonuclease III in presence of the various domains. HMO2-BoxA protects DNA 
from exonuclease III digestion at high protein concentrations (Fig. 3.9A, lanes 4-6 [1000, 2000 
and 3000 nM]). By comparison, full-length HMO2 protects DNA ends at 1000 nM protein (Fig. 
3.9B, lane 6). In contrast, HMO2-BoxB and HMO2-BoxBC are unable to protect DNA from 
exonuclease III digestion (Fig.3.9B, lanes 4 and 5). Taken together, these data suggest that the 







Figure 3.8: Ligase-mediated DNA end-joining in presence of HMO2-BoxA and HMO2-BoxB. 
(A) DNA with overhangs (5′-TA extensions) and increasing concentrations of HMO2-BoxA. 
Lane 1, 100 ng of DNA (~4 nM, corresponding to ~8 nM DNA ends). Lane 2, DNA and T4 
DNA ligase. Lanes 3–13, DNA, T4 DNA ligase, and 10, 25, 50, 75, 100, 250, 500, 750, 1000, 
2000 and 3000 nM HMO2-BoxA. Lane 14, DNA, T4 DNA ligase, 3000 nM HMO2-BoxA and 
exonuclease III. (B) DNA with overhangs (5′-TA extensions) and increasing concentrations of 
HMO2-BoxB. Lane 1, 100 ng of DNA. Lane 2, DNA and T4 DNA ligase. Lanes 3–13, DNA, T4 
DNA ligase, and 10, 25, 50, 75, 100, 250, 500, 750, 1000, 2000 and 3000 nM HMO2-BoxB. 
Lane 14, DNA, T4 DNA ligase, 3000 nM HMO2-BoxB and exonuclease III. Ligation product 















Figure 3.9: Exonuclease protection. (A) Lane 1, DNA only. Lane 2, DNA treated with 
exonuclease III for 1 h. Lane 3, DNA and 3000 nM HMO2-BoxA. Lanes 4, 5, and 6, DNA with 
1000, 2000 and 3000 nM HMO2-BoxA incubated with exonuclease III for 1 h. (B) Lane 1, DNA 
only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA 3000 nM HMO2-BoxB. 
Lanes 4 and 5, DNA incubated with 3000 nM HMO2-BoxB and HMO2-BoxBC, respectively, 
and exonuclease III for 1 h. Lane 6, DNA incubated with 1000 nM HMO2 and exonuclease III 



















Box B Is Unique in Its Preferred Binding to Static Bends and the Abasic 
Site 
  
HMO2 like other HMGB proteins comprises of two HMG domains namely Box A and 
Box B and an acidic C-terminal tail (10, 23). While Box B corresponds to mammalian Box B, 
Box A bears little resemblance to mammalian Box A (23). HMO2 resembles mammalian HMGB 
proteins because of the acidic C-terminal tail. It has earlier been reported that HMO2 has 
preferred binding for 50 bp DNA with tandem pair of mismatches (23). Also HMGB proteins 
have been shown to bind to cruciform DNA structures (31). Here we found that both HMO2-Box 
A and Box B bind to DNA with tandem pair of mismatches, however Box-BC shows reduced 
DNA binding, which could be attributed to the negatively charged C-terminal tail. It has been 
reported for mammalian HMGB that the C-terminal tail diminishes DNA binding in vitro, but 
also reduces preferences for bent DNA (32, 33).  
 Interestingly, Box B showed preferred binding for DNA with abasic site and DNA with 
stem and loop (figures 3.3C and 3.5C) indicating its preference for static DNA distortions. In 
contrast, Box A and Box BC does not have much preference for these DNA constructs. In the 
case of mammalian HMGB proteins it binds weakly with non-distorted DNA compared to DNA 
with cruciforms or bent structures (34, 35). Mammalian HMGB1 DNA intercalating residues are 
present in helix I and helix II, which renders its preference for distorted DNA. In HMO2 Box B, 
a leucine located in helix I is speculated to be the intercalating residue. It is interesting to note 
that there is a slight difference in migration of the complex in case of the different HMO2 
variants binding to 50 bp DNA duplex with tandem pair of mismatches and also the single 
mismatch. Complexes with Box A migrate slightly slower than those in case of Box B (compare 
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fig. 3.2 A/D with B/E), which could be due to the interaction of the two domains with the DNA 
substrate. This could be attributed to the stoichiometry by which Box A and Box B interacts with 
the DNA. Also it might be that Box A and Box B on interaction with the DNA substrate distorts 
the DNA and thus the complexes with Box B migrate faster than those with Box A. There could 
also be the possibility that the pI or the iso-electric point of the two domains might affect 
migration of the complexes. The estimated pI of Box A is 9.20, for Box B it is 6.25 and for Box 
BC it is 4.8. The pH of the reaction is 7.5, thus for Box A, it would be net positively charged thus 
migrating slower in the gel. It has been earlier shown that HMGB has high preference for DNA 
with loops (34). But the complex with Box-BC migrates further slower than Box B (compare 
fig.3.2 B/E with C/F), which could be due to the stoichiometry by which Box-BC interacts with 
the DNA. In case of Box-BC interacting with the DNA with abasic site and DNA with tandem 
pair of mismatches, there is a faster migrating complex C1 at higher protein concentrations 
indicated in fig.3.3 D and fig.3.2 C, but not with DNA with the single mismatch CT indicated in 
fig.3.2 F; this could be attributed to the difference in the number of mismatches present in the 
DNA. Assuming that the predominant complex with HMO2-BoxBC is a dimer, the faster 
migrating complex may be disfavoured on DNA with a single lesion because an additional lesion 
does not restrict binding of a second protomer; this interpretation also implies that 9 bp spacing 
between lesions is suboptimal for binding of two molecules of HMO2-BoxBC. 
 HMGB proteins have been earlier reported to bind to four-way junctions (15). Full length 
HMO2 has modest preference for four-way junctions (23) but HMO2-Box A forms several 
complexes with the four way junctions as indicated in figure 3.6A. Whereas Box B binds to four-
way junctions, it does not form discrete complexes with Holliday junctions (figure 3.6B). In case 
of mammalian HMGB proteins, Box A has been shown to have preference for four way junctions 
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(11, 36). For mammalian Box A, a hydrophobic residue in helix II (indicated in table 3.1A) 
enhances its affinity for distorted DNA. In case of HMO2-Box A a leucine in helix II (indicated 
in table 3.1 A and Fig. 3.10 B) is predicted to confer preference for DNA with distortions and for 
HMO2-Box B a leucine in helix I is predicted to be the DNA intercalating residue (shown in 
table 3.1 A and Fig.3.10 C). (23). Earlier it has been shown in case of mammalian HMGB 
proteins, the Box A and Box B has preference for DNA distortions with Box B having preference 
for DNA loop and Box A having preference for four way junctions  (15, 34, 35). The sequence 
alignment of mammalian HMGB1 Box A, HMGB1 Box B, SRY from the SRY.Bdidomain (12), 
Nhp6a, HMO2 Box A and HMO2 Box B indicates the hydrophobic intercalating residues (table 
3.1 A). An intercalating residue in helix II for HMO2 Box B as based on this sequence alignment 
would be consistent with its preference for distorted DNA, as seen for mammalian HMGB box A 
(table 3.1 A and Fig.3.10 C) and Nhp6a. 
HMO2-HMO2 Interactions 
Earlier, oligomerization of HMG proteins has been addressed in (38), and similarly we tried to 
elucidate HMO2-HMO2 interactions wherein HMO2 is fused with two different N-terminal tags, 
his tag and Gst tag and their interaction with 50 bp DNA with tandem pair of mismatches and 
supercoiled pGEM5 was determined. The Gst-HMO2 is almost double in molecular weight than 
his-HMO2 and thus it is expected that the respective complexes they form with DNA would 
migrate different. A difference in migration of the complexes with supercoiled plasmid pGEM5 
when incubated with his-HMO2 and Gst-HMO2 is seen (fig. 3.7 top panel). On the supercoiled 
DNA, his-HMO2 forms complex indicated in fig.3.3 lanes 2-7, but migration of the complex is 
inhibited when supercoiled DNA is incubated with equimolar concentrations of his-HMO2 and 








HMGBA           -------GKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA 
HMGBB           PKGETKKKFKDPNAPKRPPSAFFLFCSEYRPKIKGEHPG--LSIGDVAKKLGEMWNNTAA 
Nhp6a           ----TTRKKKDPNAPKRALSAYMFFANENRDIVRSENPD--ITFGQVGKKLGEKWKALTP 
HMO2B           -TKRHKVKERDPNMPKRPTNAYLLYCEMNKERIRQNGSL---DV—-TRD-LAEGWKNLNE 
SRY             -----------QDRVKRPMNAFIVWSRDQRRKMALENPR--MRNSEISKQLGYQWKMLTE 
HMO2A           ----------------QNVVLGLAIQRSRLSVKRLKLE-YGVLLERLESRIELD------ 
 
    
HMGBA           KE-KGKFEDMAKADKARYEREMKT-----------Y--------------IPPKGETKK 
HMGBB           DD-KQPYEKKAAKLKEKYEKDIAA-----------YRAKGK------------------ 
Nhp6a           EE-KQPYEAKAQADKKRYESEKEL-----------YNATLA------------------ 
HMO2B           QD-RKPYYKLYSEDRERYQMEMEI-----------YNKKISNIDADDDKEENEQKIKNN 
SRY             AE-KWPFFQEAQKLQAMHREKYPN-----------YKY---------------------
HMO2A           PELNCEDPLPTLASFKQELLTKPFRKSKT------------------------------- 
 
                                    
Table 3.1 (A) Sequence alignment of HMGB1-Box A (HMGBA), HMGB1-Box B (HMGBB), 
SRY from the SRY.B didomain (SRY) (12), Nhp6a, HMO2 Box B (HMO2B) and HMO2 Box A 
(HMO2A).The intercalating residues in helix I of HMGBA, HMGBB, Nhp6a, SRY and HMO2 
Box B are highlighted in red and those in helix II are highlighted in green. For HMO2 Box A the 
predicted helix I is highlighted in teal color and helix II highlighted in cyan. The predicted 
leucine residue in helix II of HMO2 Box A is highlighted in green.    (Sequence alignment 
generated using MAFFT version 6). HMO2 was modelled using ESyPred3D in exspasy.com (37) 
and the model of HMO2 was predicted using pdb accession id 2GZK as template (12). The 
modeling did not include sequence upstream of the R indicated in pink in the sequence and the 
helix was arbitrarily extended to match the length of the others. 
 
 





B      C 
   
 
Fig.3.10 3.1.3D model of HMO2 was obtained using ESyPred3D in exspasy.com (37) and the 
model of HMO2 was predicted using pdb accession id 2GZK as template (12). (B) Overlay of 
the SRY (in green) from SRY.B didomain (12) and HMO2 Box A (in orange). The intercalating 
residue isoleucine in helix I for SRY indicated in red and that for HMO2 Box A, a leucine in 
helix II indicated in blue.(C) Overlay of the B domain (in cyan) from SRY.B didomain and 
HMO2 Box B (in orange). The intercalating residues phenylalanine in helix I and isoleucine in 
helix II for SRYB indicated in red and a leucine in helix I and valine in helix II indicated in green 
for HMO2 Box B. The 3D structures are generated using PyMol. 








with DNA would migrate different. A difference in migration of the complexes with supercoiled 
plasmid pGEM5 when incubated with his-HMO2 and Gst-HMO2 is seen (fig. 3.7 top panel). On 
the supercoiled DNA, his-HMO2 forms complex indicated in fig.3.3 lanes 2-7, but migration of 
the complex is inhibited when supercoiled DNA is incubated with equimolar concentrations of 
his-HMO2 and Gst-HMO2 seen in lanes 16-21. 
This suggests that the Gst tag interferes with HMO2-HMO2 interaction preventing its 
interaction with supercoiled DNA. But no difference in migration of the complex was observed 
with 50 bp DNA duplex with tandem pair of mismatches figure 3.7 bottom panels A, B and C. In 
this case also it could be anticipated that the Gst tag interferes with HMO2-HMO2 interactions, 
thus inhibiting complex formation. Also there could be a possibility of presence of other 
complexes in solution, but under electrophoretic conditions the most stable complex is indicated.  
DNA-end Protection 
 Earlier it was shown that full-length HMO2 has the remarkable ability to protect DNA 
ends from exonucleolytic cleavage (23), which could be further attributed to the divergent 
HMO2-Box A indicated in figure 3.8A. HMO2-Box B and Box-BC does not have the ability to 
protect DNA from exonuclease cleavage (figure 3.9B). Although HMO2 prevents DNA end-
joining, neither HMO2-Box A nor Box B at lower protein concentrations inhibit DNA end-
joining (figure 3.8 A and B), but at higher protein concentrations both the domains prevent DNA 
end-joining like the full length protein. Both HMO2-Box A and Box B also prevent end-joining 
at higher protein concentration for shorter DNA fragments, e.g., 105 bp DNA (data not shown).  
Thus the unique DNA-end binding property of HMO2 can be concluded to be due to the HMO2-
Box A. Considering that HMO2 is a part of the ATP-dependent chromatin remodelling complex 
INO80, which helps in double strand break repair in yeast (39-41), after double strand break 
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even the DNA is exposed to cellular nucleases that resect the DNA from the end. So it could be 
speculated that HMO2 with its divergent Box-A protects the DNA ends from degradation thus 
restricting error-prone repair or severe mutations. 
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  HMO2 MEDIATES BOTH 3′ AND 5′ DNA STRAND INVASION 
Introduction 
Homologous recombination (HR) is a DNA repair pathway, which is very important for 
repair of DNA double strand breaks (DSB) and also aids in recovery of stalled DNA replication 
forks (1). HR is active during the S and G2 phase due to the presence of sister chromatids during 
these two phases (2). RAD52 epistasis group genes including RAD50, RAD51, RAD52, RAD54, 
RAD55, RAD57, RAD59, MRE11 and XRS2 have been reported to be required for DSB repair 
by this mechanism (3). During DNA damage, the damage sites are less accessible to repair 
proteins due to the compact structure of the chromatin (4, 5). Eukaryotes involve two ways 
namely covalent modification of the histone tails and ATP-dependent chromatin remodeling 
complexes to overcome the compactness of the chromatin. 
 Recently, an ATP-dependent chromatin remodeling complex has been characterized in 
yeast and shown to aid in DSB repair. The INO80 complex is recruited to the region of DSB by 
its interaction with damage induced phosphorylated histone H2A (γ-H2AX), phosphorylated at a 
specific serine residue. It has also been reported that this interaction requires HMO2 (4, 6-9). 
HMO2 is one of the subunits of the INO80 complex and thus might contribute to DSB repair by 
both pathways namely HR and non-homologous end-joining (NHEJ) (10, 11). 
 Earlier we have shown that HMO2 binds to DNA and exhibits properties similar to those 
of other high mobility group (HMGB) proteins. Also, a remarkable feature of HMO2 is that it 
protects DNA ends from exonuclease III (12). Here we show using D-loop assay that HMO2 has 
the ability to mediate DNA strand invasion and annealing to produce a D-loop - a crucial step in 
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recombination repair. Further, we also found that HMO2 mediates 3′ homologous strand 
invasion more efficiently than the 5′ strand invasion, indicating that the polarity of the ssDNA is 
important for the process. This suggests that HMO2 might have pivotal implications on DSB 
repair in yeast beyond just INO80 recruitment. Consistent with roles in HR, hmo2 knockout and 
hmo2rad52 knockout have slow growing phenotype in presence of hydroxyurea (HU) and UV 
radiation. 
Materials and Methods 
Strand Invasion Assay 
    A 60-mer 5′AATTCGTAATCATGGTCATAGCTGTTT 
CCTGTGTGAAATTGTTATCCGCTCACAATTCCA 3′ for the 5′ strand invasion and a 
complementary 60 mer (other-60) 
5ʹTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTAC
GAATT 3′ for 3′ strand invasion was obtained from Eurofins MWG Operon. The assay was 
designed based on (1). The 5′ -end of 60 mer and the other-60 mer was labeled using T4 
polynucleotide kinase. Various concentrations of HMO2 was pre-incubated with 50 femtomoles 
linearized pUC18 (linearized using EcoRI). Fifty femtomoles 60-mer and other-60 mer was then 
added to initiate D-loop formation. Reactions were then terminated using 2 µl of 10% SDS. 
Linearized pUC18 was also 5′-end labeled using T4 polynucleotide kinase. Complexes were 





Yeast Strains and Knock Outs  
The parent yeast strain used was DDY3. Rad52 knock out was obtained by knocking out 
the rad52 gene with kanMX. KanMX gene was amplified from plasmid pDD 777 using forward 
primer DDO785 
5′ GGAGGTTGCCAAGAACTGCTGAAGGTTCTGGTGGCTTTGGTGTGT 
TGTTGGCCAGCTGAAGCTTCGTACGC 3′ and reverse primer DDO 786 
5′AATAAATAATGATGCAAATTTTTTATTTGTTTCGGCCAGGAAGCGTTTCAGCATAG
GCCACTAGTGGATCTG 3′ (obtained from Dr. David Donze lab). The primers are designed 
such that they both have homologous region from the rad52 gene to aid homologous 
recombination. The PCR product was transformed in DDY3 and plated on YPD plates with 
kanamycin G418. The correct construct was further determined by PCR. hmo2∆ (DDY1301) was 
earlier created (16) but it was the same mating type as rad52∆, so the mating type of hmo2∆ was 
switched to alpha by mating DDY1229 and DDY1301, followed by tetrad dissection, wherein 
DDY1301 mating type was switched to alpha. hmo2 and rad52 double knockout was generated 
by mating rad52∆ (a mating type)  and hmo2∆ (alpha mating type), followed by tetrad 
dissection. The genotypes of the strains are indicated in table 4.1. 
Yeast Spot Dilution Assay 
The yeast parent strain (DDY3), hmo2∆, rad52∆, and hmo2∆rad52∆ knockout strains 
were grown in liquid YPD media for OD600 0.4 (for exponential phase and 1.0 (for stationary 
phase). 1, 2, 3 and 4µl of each strain was plated out on YPD plates, YPD + 0.01% MMS 
(methylmethane sulphonate), YPD + 100 mM HU (Hydroxyurea) and YPD treated with 5000 µ  
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Joules per centimeter squared UV radiation using the Stratalinker as the UV source. The 
different dilution used was 0, 1:10, 1:100, 1:1000 and 1:1000000. All the YPD plates were 
incubated at 30°C for 2 days. 
Results 
HMO2 Mediates Both 3′ and 5′ DNA Strand Invasion 
 Earlier we have reported that HMO2 can protect DNA ends from exonuclease III 
degradation (12). We also noted the appearance of a slow migrating DNA species, generated 
only in the presence of DNA and both HMO2 and exonuclease III, leading to speculation that 
HMO2 might promote single strand DNA invasion of a complementary duplex (12). Thus we 
performed DNA strand invasion assays to determine if HMO2 can mediate strand invasion. 
Fig.4.1 A shows 5′ DNA strand invasion by HMO2, wherein lane 1 has labeled free 60 mer, lane 
2 has labeled pUC18 to indicate the migration of labeled pUC18 by itself. Lane 3 indicates 
labeled 60 mer incubated with linearized pUC18 which is not labeled and lanes 4-6 indicate that 
in presence of HMO2, labeled 60 mer is able to invade the complementary strand in the 
linearized pUC18. Fig. 4.1(B), lanes 6-8 indicates that HMO2 has the ability to mediate 3′ DNA 
strand invasion in presence of other-60 mer and linearized pUC18. It is also noteworthy that in 
fig. 4.1 (B) lanes 6-8, with increasing HMO2 concentrations the D-loop complex fades indicating 
that HMO2 might mediate 3′ DNA strand invasion more efficiently than 5′ strand invasion 





Full-length HMO2 Is Required for the DNA Strand Invasion Process 
 HMO2 is composed of two HMG domains namely Box A and Box B followed by an 
acidic C-terminal tail. We have shown that HMO2 Box A protects DNA ends from exonuclease 
III digestion whereas HMO2 Box B and HMO2 Box BC are unable to protect DNA ends from 
exonuclease III degradation. We did a DNA strand invasion assay with HMO2 Box A and 
HMO2 Box B to determine if any individual domain can mediate DNA strand invasion. Fig.4.2 
lane 1 has labeled free 60 mer, lane 2 indicates labeled linearized pUC18, lanes 3 and 9 indicate 
free 60 mer and other-60 mer incubated with unlabeled linearized pUC18, lanes 4-8 show that 
with increasing concentrations of HMO2 Box B it does not promote 5′ DNA strand invasion in 
presence of 60 mer and linearized pUC18. Similarly, lanes 10-15 indicate that HMO2-Box B is 
unable to mediate 3′ DNA strand invasion in presence of other -60 mer and linearized pUC18. 
Also, HMO2-Box A is unable to promote D-loop formation (data not shown). Thus, it is evident 
that full-length HMO2 is required for 5′ and 3′ DNA strand invasion and individual domains 
HMO2 Box A and HMO2 Box B do not individually promote DNA strand invasion.  
hmo2∆ and hmo2rad52∆ Have Slower Growth Phenotype in Presence of 
HU and When Irradiated with UV 
 
We deleted hmo2 and rad52 genes with ura3 and kanMX marker genes. Further, we also 
mated hmo2∆ and rad52∆ to produce a hmo2∆rad52∆ double knockout strain. We then analyzed 
the sensitivity of the yeast wild-type, hmo2∆, rad52∆, and hmo2∆rad52∆ to MMS, HU and UV 
radiation. All the strains were grown in liquid YPD and cells were grown to OD600 0.4 for 






Figure 4.1: 5′ and 3′ DNA strand invasion by HMO2. (A) and (B) with 50 femtomoles of 
linearized pUC18, increasing concentrations of HMO2 and 50 femtomoles of single stranded 60 
mer. (A) Lane 1, reaction with labeled single stranded 60 mer, lanes 2 with labeled pUC18, lane 
3, labeled 60 mer and unlabeled linearized pUC18. Lanes 4-6 with unlabeled linearized pUC18, 
labeled 60 mer and 250, 500 and1000nM HMO2. (B) Lane 1, labeled 60 mer and unlabeled 
linearized pUC18, lanes 2-4 with unlabeled linearized pUC18, labeled 60 mer for 5′ strand 
invasion and and 250, 500 and1000nM HMO2 lane 5, labeled 60 mer and unlabeled linearized 
pUC18,. Lanes 6-8 with unlabeled linearized pUC18, labeled 60 mer for 3′ strand invasion and 






Figure 4.2: 5′ and 3′ DNA strand invasion by HMO2 Box B. (A) Lane 1, reaction with labeled 
single stranded 60 mer, lanes 2 with labeled pUC18, lane 3, labeled 60 mer and unlabeled 
linearized pUC18. Lanes 4-8 with unlabeled linearized pUC18, labeled 60 mer (for 5′ strand 
invasion) and 50, 100, 250, 500 and1000 nM HMO2-Box B, lane 9, labeled 60 mer and 
unlabeled linearized pUC18, lanes 10-15 with unlabeled linearized pUC18, labeled 60 mer (for 








Fig.4.3 indicates the sensitivity of the four strains at exponential phase in presence of MMS, HU 
and UV radiation; the four strains were also grown on YPD solid media without any damaging 
agent treatment. In presence of the alkylating agent MMS, no significant difference was 
observed in the knockout strains when compared to the wild type. But there was a significant 
difference observed in the case of treatment with HU, where the knockouts are more sensitive to 
HU than WT; hmo2∆ was more sensitive than rad52∆ and hmo2∆rad52∆ is worse than hmo2∆. 
When the four strains were irradiated with UV, hmo2∆ and rad52∆ have slower growth than the 
wild type, but hmo2∆rad52∆ growth was even slower than the single knock outs. Similar 
sensitivity patterns for the four strains have been observed at stationary phase as indicated in 
fig.4.4. 
 HMO2 has been shown to be a subunit in ATP-dependent chromatin remodeling complex 
with helps in DSB repair (4) and Rad52 is involved in HR to mediate DSB repair (3). Thus it is 
evident from the sensitivity assay that when cells were irradiated with UV, which among other 
forms of damage creates DNA double strand breaks, rad52∆, hmo2∆ and hmo2∆rad52∆ knock 
outs have slower growth phenotypes. Also when treated with hydroxyurea, which stalls the 
replication fork, hmo2∆ was observed to have slower growth than rad52∆ and hmo2∆rad52∆ 
was comparable to hmo2∆. In presence of MMS, which is a DNA alkylating agent, that 
methylates the DNA but does not induce any DSB, no significant difference in growth was 
observed the four strains. Similar growth patterns were observed for exponential and stationary 
growth phase. Thus it can be concluded that in absence of HMO2 the cells have impaired 
replication (sensitivity to HU) and that HMO2 might play an important role to aid recovery of 







Figure 4.3: Growth comparison of yeast wild-type and knockouts at exponential phase in 
presence of different DNA damaging agents. (A) Growth of yeast wild-type, hmo2∆, rad52∆ and 
hmo2∆rad52∆ on YPD media. (B) Growth of yeast wild-type, hmo2∆, rad52∆ and 
hmo2∆rad52∆ on YPD media with 0.01% methyl methane sulfonate (MMS). (C) Growth of 
yeast wild-type, hmo2∆, rad52∆ and hmo2∆rad52∆ on YPD media with 100 mM hydroxyurea 
(HU). (D) Growth of yeast wild-type, hmo2∆, rad52∆ and hmo2∆rad52∆ on YPD media and 
treat with UV radiation. All the plates were grown at 30°C for 2 days. The growth difference 









Figure 4.4: Growth comparison of yeast wild-type and knockouts at stationary phase in presence 
of different DNA damaging agents. (A) Growth of yeast wild-type, hmo2∆, rad52∆ and 
hmo2∆rad52∆ on YPD media. (B) Growth of yeast wild-type, hmo2∆, rad52∆ and 
hmo2∆rad52∆ on YPD media with 0.01% methyl methane sulfonate (MMS). (C) Growth of 
yeast wild-type, hmo2∆, rad52∆ and hmo2∆rad52∆ on YPD media with 100 mM hydroxyurea 
(HU). (D) Growth of yeast wild-type, hmo2∆, rad52∆ and hmo2∆rad52∆ on YPD media and 
treat with UV radiation. All the plates were grown at 30°C for 2 days. The growth difference 










It has already been shown that Rad52 epistasis group is involved in DSB repair (3). DSB 
is induced in DNA due to ionization radiation. UV radiation causes bulky lesions in the DNA 
and these bulky lesions are repaired by nucleotide excision repair (NER). Recently INO80 has 
been shown to aid in NER(13). But it was interesting to note the hmo2∆ strain is particularly 
sensitive to HU which stalls DNA replication fork. INO80 has been earlier reported to play a role 
in recovering stalled replication forks, and ino80∆ strains are sensitive to HU (4). HMO2 being a 
component of INO80 complex might have a role in repair of broken replication forks and 
recovery of stalled replication, thus hmo2∆ strain is sensitive to HU treatment.  
 It was reported earlier that HMO2 is required to recruit the INO80 complex to DSB by its 
interaction with phosphorylated H2A (γ-H2AX), the event being damage dependent. It is 
observed that hmo2∆ is very sensitive to HU compared to the wild type and rad52∆ strains. 
Stalling of the replication fork is also lethal in ino80∆ strain (14). It has also been reported that 
histone H2AX is also phosphorylated under replication stress (15). Thus it could be speculated 
that HMO2 in concert with phosphorylated H2AX might also help the INO80 machinery to 
assemble on stalled DNA replication forks. 
 Also since HMO2 is a subunit of a chromatin remodeling complex which aids in DSB 
repair and we show here that HMO2 by itself can mediate 5′ and 3′ DNA strand invasion, it can 
be speculated that HMO2 night have pivotal repair and recombination function beyond INO80 
recruitment to DSB. 
 Although HMO2 promotes both 5′ and 3′ strand invasion fig. 4.1 (A) and (B), 3′ strand 
invasions is carried out more efficiently, indicating that the polarity of the ssDNA is important 
for this function. Similar properties have also been reported for human Rad51, which mediates 
strand invasion with help of RPA proteins (3). 
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 Rad52 is the main DSB repair protein which functions via HR, so it could be further 
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SUMMARY AND CONCLUSIONS 
  
All organisms‟ genomes are subject to damage either from endogenous sources or from 
the environment. The lesions formed due to these damaging agents could be a threat for the 
proliferating cells. Thus there should be an efficient way to respond to these DNA damages by 
recognition of the lesions and then removal of these lesions to restore the genome from errors 
and mutations (1).  
Several chromatin proteins have been identified that bind to damaged DNA. Recently the 
ATP-dependent chromatin remodeling complex INO80 has been reported to aid in double strand 
break (DSB) repair in yeast (2-6). The INO80 is recruited to the region of DSB by interaction 
with damaged induced signal response, phosphorylated histone H2A (γ-H2AX), and this 
interaction requires HMO2. INO80 has also been recently reported to aid in nucleotide excision 
repair (7, 8) and to help in recovery of stalled DNA replication forks (9).  In this dissertation, I 
characterize the protein HMO2 and its DNA binding properties. 
DNA Binding by HMO2 and Its Variants 
 HMO2 is one of the ten HMGB proteins in yeast (10). It consists of two HMG domains 
namely Box-A and Box-B, followed by an acidic C-terminal tail (11). The occluded DNA site 
size for an HMG domain is ~10 bp (12-15). Since HMO2 consists of two HMG domains, it 
should be able to bind a ~20 bp DNA, however our data suggests that HMO2 weakly binds to 37 
bp DNA with two loops but binds to 50 bp with 2 loops with higher affinity (11). Thus it could 
be likely that HMO2 binds as a dimer in case of the 50 bp DNA with loops, although this 
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stoichiometry may not apply for HMO2 interaction with perfect DNA duplex, as the loops may 
impose a constraint, like greater preference of one of the domains for the 4-nt loops compared to 
the other domain. In case of the two individual HMG domains, HMO2-BoxA and HMO2-BoxB 
bind to 50 bp DNA with two 4-nt loops and form a stable complex. Also, the complex with 
HMO2-BoxB migrates slightly faster than that formed with HMO2-BoxA, which may be 
attributed to a difference in the modes of binding of the two domains with the DNA, such as 
differences in stoichiometry or DNA bend angles. HMO2-BoxBC also forms a complex with this 
DNA construct but the complex migrates much slower than that formed with HMO2-BoxA and 
HMO2-BoxB, suggesting that the negatively charged C-terminal tail significantly modulates 
DNA binding by Box B, perhaps by favoring binding by a dimer of HMO2-BoxBC.  
HMO2 binds significantly better to DNA with tandem lesions compared to DNA with a single 4-
nt loop (11); in contrast, HMO2-BoxA, HMO2-BoxB, and HMO2-BoxBC form a single 
complex on DNA with a single 4-nt loop comparable to that seen with DNA with tandem 
lesions, except that HMO2-BoxB is more prone to forming multiple complexes  perhaps 
reflecting that a second lesion attenuates a protein accretion otherwise seen in its absence. 
Full-length HMO2 binds well to the DNA construct containing the abasic site, forming a single 
complex, however, HMO2-BoxA does not form stable complexes with this construct and 
HMO2-BoxBC binds more stably compared to DNA with single or tandem 4-nt loops and 
HMO2-BoxB forms multiple complexes with this DNA construct. Evidently, the differential 
DNA distortion imposed by tandem mismatches and abasic sites significantly affects the binding 
mode of the HMO2 domains. I further examined the interaction of HMO2 domains with 
statically deformed DNA and found that HMO2-BoxB forms several complexes with this DNA 
construct suggesting that Box B exhibits a binding preference for static DNA distortions.  
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 HMGB proteins also bind preferably to four-way DNA junctions (16, 17), while HMO2 
does bind four-way DNA junctions with modest preference. For mammalian HMGB1, binding to 
four-way DNA junctions is mediated by the Box A domain (17). This selectivity arises from 
using a hydrophobic residue from helix II of the HMG fold as a bending wedge. Like 
mammalian HMGB proteins, HMO2-BoxA forms multiple discrete complexes with four-way 
junctions. But complexes with HMO2-BoxB dissociate during electrophoresis and HMO2-
BoxBC fails to form detectable complex. In HMO2 Box B, a leucine located in helix I is 
speculated to be the intercalating residue, whereas in HMGB1 DNA intercalating residues are 
present in helix I and helix II, which renders its preference for distorted DNA 
DNA-end Protection 
The remarkable ability of HMO2 to protect certain DNA constructs from exonucleolytic 
cleavage and to prevent their end-joining in presence of T4 DNA ligase, suggests its preferred 
binding to these DNA ends. HMO2 protects DNA with blunt ends efficiently, while in case of 
DNA with overhangs, the sequence of the single stranded overhang significantly affects HMO2 
binding (11). Considering that HMO2 is a part of the ATP-dependent chromatin remodelling 
complex INO80, which helps in double strand break (DSB) repair (2, 5) after double strand 
break even the DNA is exposed to cellular nucleases that resect the DNA from the end. Amongst 
the different domains of HMO2, Box A was shown to protect DNA from exonuclease III 
cleavage, whereas HMO2 Box B and Box BC could not protect the DNA from such cleavage. So 
it could be concluded that HMO2 with the help of the divergent Box-A protects the DNA ends 




HMO2 Is Required for the DNA Strand Invasion Process 
 HMO2 is a subunit of a chromatin remodeling complex INO80 (5), which aids in DSB 
and we show here that HMO2 by itself can mediate 5′ and 3′ DNA strand invasion; it can 
therefore be speculated that HMO2 might have pivotal repair and recombination function beyond 
INO80 recruitment to DSBs, although individual domains HMO2 Box A and HMO2 Box B do 
not individually promote DNA strand invasion. 
hmo2∆ and hmo2rad52∆ Have Slower Growth Phenotype in Presence of HU 
and When Irradiated with UV 
 HMO2 has been shown to be a subunit in ATP-dependent chromatin remodeling complex 
with helps in DSB repair (5). It is evident from the sensitivity assay that when cells were 
irradiated with UV, which among other forms of damage creates DNA double strand breaks, 
rad52∆, hmo2∆ and hmo2∆rad52∆ knock outs have slower growth phenotype. It is also worthy 
of mention that UV radiation also introduces bulky lesions in the DNA, which are repaired by 
nucleotide excision repair (NER). Recently the INO80 complex has been shown to aid in NER 
(7). Also when treated with hydroxyurea, which stalls the replication fork, hmo2∆ was observed 
to have slower growth than rad52∆ and hmo2∆rad52∆ was comparable to hmo2∆. Thus it can be 
concluded that in absence of HMO2 the cells confer sensitivity to HU, indicating impaired 
replication (sensitivity to HU) and that HMO2 might play an important role to aid recovery of 
stalled replication fork. 
 HMO2 has been shown to be a part of the INO80 chromatin remodeling complex (5) and 
it is remarkable indeed that although it is a part of a complex, it has the ability to perform 
independent functions like DNA binding, DNA-end protection and DNA strand invasion. All 
these functions imply that HMO2 might aid INO80 in DNA recognition and repair. It is 
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important point to note is that HMO2 is needed for INO80 to interact with gamma-H2AX, but 
direct interaction has not been shown. This work shows that HMO2 binds preferentially to DNAs 
that are targets for INO80. Therefore, a valid speculation is that direct interaction of HMO2 with 
DNA contributes to recruitment of INO80, along with interaction of either H2AX or other 
INO80 subunits with the phosphorylated histone. 
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